paclitaxel has been researched along with Cardiovascular Stroke in 452 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (1.11) | 18.2507 |
| 2000's | 170 (37.61) | 29.6817 |
| 2010's | 269 (59.51) | 24.3611 |
| 2020's | 8 (1.77) | 2.80 |
| Authors | Studies |
|---|---|
| Amoroso, G; Herrman, JR; Niehe, SR; Patterson, MS; Slagboom, T; Van Der Schaaf, RJ; Vink, MA; Vos, NS | 1 |
| Amoroso, G; Herrman, JR; Patterson, MS; Slagboom, T; van der Schaaf, RJ; Vink, MA; Vos, NS | 1 |
| Alvarez-Covarrubias, HA; Cassese, S; Giacoppo, D; Hochholzer, W; Joner, M; Kastrati, A; Kessler, T; Koch, T; Kufner, S; Laugwitz, KL; Schunkert, H; Wiebe, J; Xhepa, E | 1 |
| Alfonso, F; Cortese, B; Erriquez, A; Rivero, F; Testa, G | 1 |
| Funatsu, A; Kobayashi, T; Mizobuchi, M; Nagai, T; Nakamura, S | 1 |
| Hayata, K; Katsuda, M; Kitadani, J; Nakamori, M; Nakamura, M; Ojima, T; Yamaue, H | 1 |
| Bhak, Y; Choi, BJ; Garg, S; Hao, J; Hui, L; Jun, EJ; Kim, TH; Kun, L; Qiang, T; Shin, ES; Sohn, CB; Yuan, SL; Zhentao, S; Zhi, W | 1 |
| Ji, F; Wang, F; Wang, X; Xu, F; Yang, C; Yu, X; Zhang, W | 1 |
| Gao, RL; He, C; Jiang, L; Ma, YL; Tang, XF; Wang, CS; Xu, B; Yao, Y; Yuan, JQ; Zhang, JH | 1 |
| Bellone, P; Benfari, G; Botta, M; Cordone, S; Cuman, M; Fede, A; Ghione, M; Lunardi, M; Pacchioni, A; Reimers, B; Ribichini, FL; Zivelonghi, C | 1 |
| Baber, U; Camenzind, E; Chieffo, A; Dangas, GD; Faggioni, M; Farhan, S; Galatius, S; Giustino, G; Harari, R; Itchhaporia, D; Jeger, RV; Kandzari, D; Kastrati, A; Kim, HS; Kimura, T; Leon, MB; Mehran, R; Mehta, L; Morice, MC; Sartori, S; Serruys, PW; Sharma, M; Smits, PC; Sorrentino, S; Stefanini, GG; Steg, PG; Stone, GW; Valgimigli, M; Von Birgelen, C; Weisz, G; Wijns, W; Windecker, S | 1 |
| Bhurtu, A; Bundhun, PK; Huang, WQ; Pursun, M; Soogund, MZS; Teeluck, AR | 1 |
| Cui, Y; Fan, X; Kong, J; Li, J; Liu, P; Wen, J; Ye, Z; Zhang, J; Zhen, Y; Zheng, X | 1 |
| Ashikaga, T; Fukushima, T; Hatano, Y; Isobe, M; Ueshima, D; Yamamoto, T; Yasuhiro, M; Yoshikawa, S | 1 |
| Arshad, MKM; Ho, HH; Jafary, FH; Loh, JKK; Ong, PJL; Tan, CK; Tin, ZL; Watson, T | 1 |
| Garg, S; Her, AY; Kim, YH; Shin, ES | 1 |
| Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F | 1 |
| Chen, DY; Chen, SW; Chen, TH; Cherng, WJ; Chu, PH; Hsieh, IC; Hung, MJ; Mao, CT; Tseng, CN; Wang, CH; Wen, MS | 1 |
| Holm, NR; Neghabat, O | 1 |
| Ali, ZA; Ben-Yehuda, O; Gkargkoulas, F; Gore, AK; Konigstein, M; Madhavan, MV; Maehara, A; McAndrew, T; Mehdipoor, G; Rahim, HM; Redfors, B; Shlofmitz, E; Srdanovic, I; Stone, GW | 1 |
| Kotani, J; Kozuma, K; Nakamura, M; Okura, H | 1 |
| Bourantas, C; Garg, S; Serruys, PW | 1 |
| Brener, SJ; Brodie, BR; Guagliumi, G; Inaba, S; Kellett, MA; Maehara, A; Mehran, R; Mintz, GS; Stone, GW; Witzenbichler, B; Xu, K; Yakushiji, T | 1 |
| Bajwa, HS; Ball, MW; Coleman, PS; Cutlip, DE; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; Papadakos, S; Sketch, MH; Stoler, RC | 1 |
| Abizaid, A; Botelho, R; Cristea, E; Den Heijer, P; Erbs, S; Haude, M; Koh, TH; Lee, SW; Maehara, A; Mehran, R; Meredith, I; Parise, H; Rosli, MA; Silber, S; Sim, KH; Stella, PR; Tan, HC; Thambar, S; Verheye, S; Whitbourn, R; Worthley, SG | 1 |
| Chang, SH; Chen, CC; Hsieh, IC; Hsieh, MJ; Lee, CH; Lin, FC; Wang, CY | 1 |
| Janus, M; Lesiak, M; Lukawski, K; Prech, M | 1 |
| Chevalier, B; Coe, J; Cutlip, DE; Dimario, C; Grube, E; Neumann, FJ; Ormiston, J; Schwartz, LB; Whitbourn, R; Williams, DO | 1 |
| Fajadet, J; Kandzari, DE; Leon, MB; Mauri, L; Meredith, I; Wijns, W | 1 |
| Barioli, A; Buja, P; D'Amico, G; Facchin, M; Frigo, AC; Iliceto, S; Isabella, G; Napodano, M; Tarantini, G | 1 |
| Brodie, B; Dudek, D; Grines, C; Kornowski, R; McAndrew, TC; Mehran, R; Metzger, C; Parise, H; Sergie, Z; Stone, GW; Witzenbichler, B; Wöhrle, J | 1 |
| Biondi-Zoccai, G; Della Riva, D; Frati, G; Galatius, S; Genereux, P; Kaiser, C; Kedhi, E; Kirtane, AJ; Mariani, A; Palmerini, T; Sabaté, M; Smits, PC; Stone, GW; Valgimigli, M | 1 |
| Almalla, M; Hoffmann, R; Marx, N; Pross, V; Schröder, J | 1 |
| Boudriot, E; Dänschel, W; Desch, S; Erbs, S; Heinz, A; Kleinertz, K; Lauer, B; Linke, A; Schloma, D; Schuler, G; Stiermaier, T; Thiele, H | 1 |
| Gunda, S; Kandzari, DE; Kirtane, AJ | 1 |
| Cao, S; Cutlip, DE; Dangas, GD; Hermiller, J; Kereiakes, DJ; Lansky, AJ; Newman, W; Rizvi, A; Serruys, PW; Smith, RS; Stone, GW; Sudhir, K; Theodoropoulos, K | 1 |
| Amico, F; Bartorelli, A; Belli, R; Beqaraj, F; Berni, A; Cabianca, E; Cappi, B; Caramanno, G; Della Rovere, F; Fiscella, A; Indolfi, C; La Vecchia, L; Lopera Quijada, MJ; Loschiavo, P; Milazzo, D; Musarò, S; Pironi, B; Ribaldi, L; Ribichini, F; Rigattieri, S; Rolandi, A; Romano, M; Rosiello, R; Sangiorgio, P; Sheiban, I; Spaccarotella, C; Trabattoni, D; Vassanelli, C; Villani, R | 1 |
| Jüni, P; Kalesan, B; Magro, M; Meier, B; Moschovitis, A; Onuma, Y; Räber, L; Serruys, PW; Stefanini, GG; Taniwaki, M; van Domburg, RT; Windecker, S | 1 |
| Bedogni, F; Berti, S; Biondi-Zoccai, G; Colombo, A; Cortese, B; Cremonesi, A; Limbruno, U; Sgueglia, GA | 1 |
| Biondi-Zoccai, G; D'Ascenzo, F; Della Riva, D; Frati, G; Genereux, P; Kaiser, C; Mancone, M; Mariani, A; Palmerini, T; Sabaté, M; Smits, PC; Stone, GW | 1 |
| Amoroso, N; Bangalore, S; Faxon, DP; Feit, F; Fusaro, M; Hannan, EL; Kumar, S; Toklu, B | 1 |
| Cutlip, DE; Gada, H; Hermiller, JB; Hou, L; Kirtane, AJ; Koo, K; Mahaffey, KW; Newman, W; Sanz, M; Stone, GW; Sudhir, K | 1 |
| Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Marchesini, J; Minarelli, M; Parrinello, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P | 1 |
| Bourantas, CV; Dawkins, KD; Diletti, R; Farooq, V; Feldman, TE; Girasis, C; Holmes, DR; Morel, MA; Morice, MC; Muramatsu, T; Onuma, Y; Serruys, PW; van Es, GA | 1 |
| Cohen, DJ; Han, JK; Hwang, SS; Kandzari, DE; Kang, DY; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lim, WH; Oh, BH; Park, KT; Park, KW; Park, YB | 1 |
| Aarøe, J; Bligaard, N; Galløe, AM; Hansen, PR; Jeppesen, JL; Lassen, JF; Saunamäki, K; Stephansen, G; Thayssen, P; Thuesen, L | 1 |
| Chae, IH; Choi, DJ; Kim, HS; Kim, JH; Lim, WH; Park, KW; Shin, DH | 1 |
| Byrne, RA; de Waha, A; Joner, M; Kastrati, A; Kufner, S; Laugwitz, KL; Schulz, S | 1 |
| Kitabata, H; Laynez-Carnicero, A; Loh, JP; Pichard, AD; Sardi, GL; Satler, LF; Torguson, R; Waksman, R; Xue, Z | 1 |
| Chechi, T; de la Llera, LS; De Luca, G; Di Lorenzo, E; Dirksen, MT; Kaiser, C; Kelbæk, H; Musto, C; Pasceri, V; Schalij, M; Spaulding, C; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; van der Hoeven, B; Vink, MA; Violini, R | 1 |
| Badr, S; Barbash, IM; Ben-Dor, I; Loh, JP; Minha, S; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
| Basavarajaiah, S; Bertoldi, L; Carlino, M; Chieffo, A; Colombo, A; Costopoulos, C; Figini, F; Latib, A; Montorfano, M; Naganuma, T; Shannon, J; Sticchi, A | 1 |
| Allocco, D; Dawkins, KD; Ellis, SG; Guagliumi, G; Jiang, S; Kobayashi, N; Maehara, A; McAndrew, TC; Mintz, GS; Ormiston, JA; Stone, GW; Turco, MA; Weissman, NJ; Witzenbichler, B | 1 |
| Bangalore, S; Feit, F; Toklu, B | 1 |
| Chechi, T; De Luca, G; Di Lorenzo, E; Dirksen, MT; Kaiser, C; Kelbæk, H; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; Vink, MA | 1 |
| Ablimit, A; Jiamali, A; Kelimu, W; Mamuti, W; Pei, X; Rao, F; Zhang, F; Zhang, W | 1 |
| Ackermann, H; Antoni, D; Bocksch, W; Boxberger, M; Cremers, B; Degenhardt, R; Hengstenberg, C; Heuer, H; Kleber, FX; Leschke, M; Maikowski, C; Scheller, B; Speck, U; Unverdorben, M; Vallbracht, C; Werner, GS | 1 |
| Fischman, DL; Jasti, B; Kaliyadan, A; Ogilby, JD; Ruggiero, NJ; Savage, MP; Siu, H; Walinsky, P | 1 |
| Joner, M; Virmani, R; Yahagi, K | 1 |
| Berti, S; Ciardetti, M; Coceani, M; Palmieri, C; Pastormerlo, LE; Ravani, M; Rizza, A; Shlueter, M; Trianni, G; Vaghetti, M | 1 |
| Jerin, M; Shammas, GA; Shammas, NW; Sharis, P | 1 |
| Amoroso, G; Dirksen, MT; Herrman, JP; Kiemeneij, F; Patterson, MS; Slagboom, T; van der Schaaf, RJ; van Nooijen, FC; Vink, MA; Vos, NS | 1 |
| Baek, K; Chun, K; Lee, S | 1 |
| Allocco, DJ; Christen, T; Garratt, KN; Jenkins, RG; Kereiakes, DJ; Lee, DP; Mauri, L; Pow, TK; Weaver, WD; Winters, KJ | 1 |
| Abdul-Jawad Altisent, O; Alfonso, F; Bosa, F; Calviño, R; de la Torre Hernández, JM; Elizaga, J; García Camarero, T; Garcia Del Blanco, B; Hernández, F; Jimenez Mazuecos, J; Jimenez Navarro, MF; Martin Yuste, V; Moreu, J; Pérez de Prado, A; Roura, G; Ruiz-Arroyo, JR; Rumoso, JR; Sánchez Recalde, A | 1 |
| Lacunza Ruiz, FJ; Montalbán Larrea, S; Pinar Bermúdez, E | 1 |
| Spitzer, E; Windecker, S | 1 |
| Abad, E; Alburquerque-Béjar, JJ; Fernández-Sanz, C; García-Dorado, D; Inserte, J; Rodríguez-Sinovas, A; Ruiz-Meana, M; Sánchez, JA | 1 |
| Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
| Brener, SJ; Brodie, BR; Ertelt, K; Genereux, P; Guagliumi, G; Mehran, R; Stone, GW; Witzenbichler, B; Xu, K | 1 |
| Banning, AP; Bourantas, CV; Campos, CM; Colombo, A; Garcia-Garcia, HM; Grech, ED; Holmes, DR; Iqbal, J; Kappetein, AP; Mack, MJ; Mohr, FW; Morice, MC; Onuma, Y; Serruys, PW; Steyerberg, EW; van Klaveren, D; Zhang, YJ | 1 |
| Hibi, K; Ikari, Y; Inoue, N; Ishiwata, S; Isshiki, T; Kozuma, K; Kyono, H; Nakayama, M; Ohta, H; Otsuka, M; Sano, K; Suematsu, N; Suzuki, N; Tanabe, K; Uehara, Y; Yamane, M; Yamauchi, Y; Yokoi, H | 1 |
| Banning, AP; Colombo, A; Escaned, J; Feldman, T; Gunn, JP; Holmes, DR; Iqbal, J; Kappetein, AP; Mack, MJ; Mohr, FW; Morice, MC; Serruys, PW; Stahle, E; Steyerberg, EW; Zhang, YJ | 1 |
| Baliulis, G; Corbett, S; Curzen, N; Kaarne, M; Olsen, S; Rawlins, J; Roubelakis, A | 1 |
| Ahn, TH; Bae, JH; Chen, KY; Hur, SH; Jeong, MH; Kim, YJ; Li, GP; Li, YJ; Oh, DJ; Rha, SW | 1 |
| Fujii, Y; Hayashi, Y; Higashihara, T; Hironobe, N; Kagawa, Y; Kawase, T; Masaoka, Y; Okimoto, T; Otsuka, M; Shiode, N; Tamekiyo, H; Yamane, K | 1 |
| Ishikawa, S; Kawashima, H; Kozuma, K; Kyono, H; Nakaya, H; Nara, Y; Suzuki, N; Watanabe, Y | 1 |
| Bossi, I; Bruschi, G; Colombo, P; De Marco, F; Klugmann, S; Oreglia, J; Piccalò, G; Soriano, F | 1 |
| Byrne, RA; Cassese, S; Fusaro, M; Hoppmann, P; Kastrati, A; Kufner, S; Laugwitz, KL; Neumann, FJ; Schulz-Schüpke, S; Schunkert, H; Valeskini, M | 1 |
| Capasso, M; Carbone, G; De Luca, G; Di Lorenzo, E; Lanni, F; Lanzillo, T; Manganelli, F; Pagliuca, MR; Palmieri, V; Rosato, G; Sauro, R; Serino, V; Suryapranata, H | 1 |
| Joesoef, KS; McFadden, EP; Royaards, KJ; Smits, PC; van de Ent, M; van Mieghem, C; Vlachojannis, GJ; Wassing, J | 1 |
| Boxberger, M; Buszman, PE; Buszman, PP; Gąsior, P; Gorycki, B; Granada, JF; Janas, A; Kondys, M; Michalak, M; Milewski, KP; Peppas, A; Żurakowski, A | 1 |
| Advani, PP; Ballman, KV; Colon-Otero, G; Dockter, TJ; Perez, EA | 1 |
| Ann, SH; Balbir Singh, G; Kleber, FX; Koo, BK; Lim, KH; Shin, ES | 1 |
| Dias, S; Petrou, P | 1 |
| Bil, J; Gil, RJ; Grundeken, MJ; Iñigo Garcia, LA; Kern, A; Pawłowski, T; Serruys, PW; Vassilev, D; Wykrzykowska, JJ | 1 |
| Birkemeyer, R; Brachmann, J; Jung, W; Markovic, S; Rittger, H; Rottbauer, W; Seeger, J; Wöhrle, J | 1 |
| Dola, J; Kawecki, D; Marcinkiewicz, K; Morawiec, B; Nowalany-Kozielska, E; Ochała, A; Pluta, A; Smolka, G; Wańha, W; Wojakowski, W | 1 |
| Abdel-Wahab, M; Allali, A; Büttner, HJ; de Waha, S; Geist, V; Khattab, AA; Neumann, FJ; Richardt, G; Toelg, R | 1 |
| Adam, J; Boudriot, E; Erbs, S; Linke, A; Mangner, N; Möbius-Winkler, S; Sandri, M; Schuler, GC; Uhlemann, M; Woinke, M | 1 |
| Dirksen, MT; Kiemeneij, F; Laarman, G; Patterson, MS; Slagboom, T; Suttorp, MJ; Vink, MA; Vos, NS | 1 |
| Berland, J; Brenot, P; Dupouy, P; Fajadet, J; Guerin, P; Lefèvre, T; Motreff, P; Schandrin, C | 1 |
| Abbott, JD | 2 |
| Chen, F; Chen, J; Chen, Y; Gao, R; Ge, J; Qian, J; Wang, J; Wei, M; Xu, B; Yang, Y | 1 |
| Bai, ZG; Gao, B; Ge, B; Meng, M; Sa, RN; Wang, X | 1 |
| Agarrado, A; Benezet, J; Del Río, A; Gamaza, S; Gutiérrez-Barrios, A; Oneto, J; Ruiz-Fernández, D | 1 |
| Bavry, AA; Park, K | 1 |
| Apruzzese, PK; Camenzind, E; Cohen, DJ; Cutlip, DE; Gershlick, AH; Kereiakes, DJ; Massaro, JM; Mauri, L; Normand, SL; Rinaldi, MJ; Secemsky, EA; Song, Y; Spertus, JA; Steg, PG; Wijns, W; Yeh, RW | 1 |
| Cao, Z; Du, X; Li, Y; Wang, C; Wang, K; Zuo, G | 1 |
| French, JK; Hee, L; Hopkins, A; Juergens, CP; Lo, S; Mussap, CJ; Terluk, A; Thomas, L | 1 |
| Billinger, M; Eberli, F; Heg, D; Jüni, P; Lüscher, TF; Moschovitis, A; Pilgrim, T; Räber, L; Schönenberger, C; Spitzer, E; Stortecky, S; Windecker, S; Yamaji, K; Zanchin, C; Zanchin, T | 1 |
| Balasubramanian, K; Cairns, J; Cantor, WJ; DeLarochellière, R; Dzavik, V; Graham, JJ; Jolly, SS; L'Allier, PL; Le May, MR; Mansour, S; Rodés-Cabau, J; Teefy, PJ; Wood, D | 1 |
| Alfonso, F; Alonso-Pulpón, L; Bethencourt, A; Brugaletta, S; Bullones, JA; Fernández-Portales, J; García Del Blanco, B; García-Touchard, A; Goicolea, J; Gonzalo, N; Hernández Pérez, FJ; Hernandez-García, JM; Jiménez-Mazuecos, J; Lezaún, R; Martínez-Romero, P; Melgares, R; Miranda, F; Ortas, R; Otzuki, S; Ruiz-Salmerón, R; Rumoroso, JR; Sabaté, M; Trillo, R; Valdés, M | 1 |
| Cho, KI; Garg, S; Her, AY; Kim, YH; Koo, BK; Shin, ES; Singh, GB | 1 |
| Amano, H; Fuku, Y; Goto, T; Habara, S; Hyodo, Y; Kadota, K; Kubo, S; Miura, K; Ohya, M; Otsuru, S; Shimada, T; Tada, T; Tanaka, H | 1 |
| Hannan, EL; Qian, F; Zhong, Y | 1 |
| Ellis, SG; Friedman, M; Kent, K; Kereiakes, DJ; Koglin, J; Martin, SL; McGarry, T; O'Shaughnessy, CD; Popma, JJ; Stone, GW; Turco, MA | 1 |
| Kornowski, R | 1 |
| Assali, A; Ben-Dor, I; Brosh, D; Fuchs, S; Kornowski, R; Lev, E; Rechavia, E; Teplitsky, I; Vaknin-Assa, H | 1 |
| Ahmed, WH; Al Naeemi, A; Al-Rashdan, I; Mascioli, S; Saeed, FA; Zambahari, R | 1 |
| Abraham, D; Bahr, RD; Hamirani, YS; Jibrin, I; Merriman, B; Wenz, C | 1 |
| Benassi, A; Campo, G; De Palma, R; Guastaroba, P; Magnavacchi, P; Manari, A; Marzocchi, A; Percoco, G; Saia, F; Sangiorgio, P; Santarelli, A; Tarantino, F; Varani, E; Vignali, L | 1 |
| Kadota, J; Miyamoto, K; Tamura, A; Watanabe, T | 1 |
| Bhatia, R; Chieffo, A; Colombo, A; Latib, A; Lee, MS; Sheiban, I; Sillano, D; Tobis, J; Zoccai, GB | 1 |
| Morrison, DA | 4 |
| Airaksinen, KE; Karjalainen, PP; Kervinen, K; Mäkikallio, T; Niemelä, M; Nyman, K; Pietili, M; Sia, J; Tuomainen, P; Ylitalo, A | 1 |
| Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, MS; Slagboom, T; Suttorp, MJ; Tijssen, JG; Vink, MA | 1 |
| Bligaard, N; Galløe, AM; Hansen, PR | 1 |
| Bonello, L; Buch, AN; De Labriolle, A; Kaneshige, K; Kent, KM; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R | 1 |
| Cutlip, DE; Kint, PP; Morel, MA; Serruys, PW; Van Es, GA; Vranckx, P | 1 |
| Bøttcher, M; Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Krusell, LR; Lassen, JF; Maeng, M; Pedersen, L; Rasmussen, K; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH | 1 |
| Kammer, RT | 1 |
| Byrne, RA; Di Lorenzo, E; Dibra, A; Iijima, R; Kaiser, C; Kastrati, A; Laarman, GJ; Mehilli, J; Menichelli, M; Ndrepepa, G; Schömig, A; Spaulding, C; Suttorp, MJ; Tierala, I; Valgimigli, M; Violini, R | 1 |
| Lanjewar, CP; Sharma, A; Sheth, T | 1 |
| Brodie, BR; Dangas, G; Dudek, D; Gersh, BJ; Guagliumi, G; Kellock, A; Lansky, AJ; Mehran, R; Möckel, M; Ochala, A; Parise, H; Peruga, JZ; Pocock, SJ; Stone, GW; Witzenbichler, B; Wong, SC | 1 |
| Bruskina, O; Byrne, RA; Dirschinger, J; Iijima, R; Kastrati, A; Laugwitz, KL; Massberg, S; Mehilli, J; Pache, J; Schömig, A; Schulz, S; Seyfarth, M | 1 |
| Alfonso, F | 1 |
| Goldstein, JA; Grines, CL; Safian, RD | 1 |
| Hannan, EL; Holmes, DR; Jones, RH; Katz, S; King, SB; Racz, M; Sharma, S; Walford, G | 1 |
| Baim, DS; Cannon, LA; Dawkins, KD; Hall, JJ; Mandinov, L; Mann, T; McGarry, TF; Mishkel, GJ; O'Shaughnessy, CD; Ormiston, JA; Popma, JJ; Turco, MA; Webster, MW | 1 |
| Barlis, P; Garcia-Garcia, HM; Gonzalo, N; Ligthart, J; Onuma, Y; Regar, E; Serruys, PW | 1 |
| Campo, G; Carletti, R; Carrescia, C; Ferrari, R; Valgimigli, M | 1 |
| Cao, S; Cristea, E; Doostzadeh, J; Guiran, JB; Lansky, AJ; Midei, M; Mutlu, H; Newman, W; Ng, VG; Sanz, M; Sood, P; Stone, GW; Su, X; Sudhir, K; White, R | 1 |
| Bocksch, W; Boxberger, M; Degenhardt, R; Gross, M; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M | 2 |
| Allocco, DJ; Baim, DS; Dawkins, KD; Leon, MB | 1 |
| Capasso, M; De Luca, G; Di Lorenzo, E; Lanzillo, T; Manganelli, F; Mariello, C; Pagliuca, MR; Rosato, G; Sauro, R; Siano, F; Stanco, G; Varricchio, A | 2 |
| Bucalo, R; Caggegi, AM; Capodanno, D; Capranzano, P; Cumbo, M; Galassi, AR; Monaco, S; Ruperto, C; Sanfilippo, A; Tamburino, C; Ussia, GP | 1 |
| Gurm, HS; Meier, P | 1 |
| Dambrink, JH; de Boer, MJ; De Luca, G; Gosselink, AT; Hoorntje, JC; Juwana, YB; Ottervanger, JP; Suryapranata, H; van't Hof, AW | 1 |
| Baim, DS; Chhabra, A; Cox, DA; Dawkins, KD; Haas, RC; Lasala, JM; Lewis, SJ; Mascioli, SR; Schweiger, MJ; Starzyk, RM; Tadros, PN; Untereker, WJ | 1 |
| Chen, KY; Choi, CU; Jin, Z; Kim, EJ; Kim, JW; Lim, HE; Minami, Y; Na, JO; Oh, DJ; Park, CG; Rha, SW; Seo, HS; Shin, SY; Suh, SY | 1 |
| Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Martinez, EE; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE | 1 |
| Vlaar, PJ; Zijlstra, F | 1 |
| Berger, P; Cohen, DJ; Cutlip, D; Goldberg, S; Hong, M; Kellett, M; Kleiman, N; Mauri, L; Novack, V; Pencina, M; Raizner, AE; Waksman, R; Yen, CH | 1 |
| Airaksinen, KE; Karjalainen, PP; Kervinen, K; Mäkikallio, T; Niemelä, M; Nyman, K; Pietilä, M; Sia, J; Tuomainen, P; Ylitalo, A | 1 |
| Londhey, VA; Parikh, FS | 1 |
| Changqi, J; Changsheng, M; Chengxiong, G; Fang, C; Fangjiong, H; Jiahui, W; Jianzeng, D; Junping, K; Qiang, L; Rong, H; Shaoping, N; Shuzheng, L; Xiaohui, L; Xin, D; Xinmin, L; Xuesi, W; Yan, Q; Yin, Z; Yujie, Z | 1 |
| Capasso, M; Carbone, G; Cortese, G; De Luca, G; Di Lorenzo, E; Lanzillo, T; Manganelli, F; Mariello, C; Pagliuca, MR; Rosato, G; Sauro, R; Siano, F; Stanco, G; Varricchio, A | 1 |
| Aharonian, VJ; Brar, SK; Brar, SS; Dangas, G; Gray, WA; Leon, MB; Moses, JW | 1 |
| Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Haagen, D; Holper, EM; Iturbe, JM; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Shunk, K; Voudris, VV | 1 |
| Choi, SW; Choi, YJ; Jeong, JO; Jo, SH; Kim, HS; Kim, YH; Ko, JK; Lee, JH; Lee, SW; Park, JH; Rhee, KS; Seong, IW | 1 |
| Chen, KY; Choi, CU; Jin, Z; Kim, EJ; Kim, JW; Li, YJ; Lim, HE; Minami, Y; Na, JO; Oh, DJ; Park, CG; Poddar, KL; Rha, SW; Seo, HS; Suh, SY | 1 |
| Brodie, B; Guagliumi, G; Kellett, MA; Lansky, AJ; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Witzenbichler, B | 1 |
| Applegate, RJ; Cao, S; Doostzadeh, J; Gordon, PC; Hermiller, JB; Lansky, AJ; Stone, GW; Sudhir, K; Weinsier, SB | 1 |
| Akin, I; Fetsch, T; Kuck, KH; Nienaber, CA; Richardt, G; Sabin, GV; Schneider, S; Senges, J; Silber, S; Stumpf, J; Tebbe, U; Willich, SN | 1 |
| Cheong, SS; Cho, YH; Hong, MK; Hong, TJ; Jeong, MH; Kim, JJ; Kim, KS; Kim, YH; Lee, CW; Lee, JH; Lee, NH; Lee, SG; Lee, SH; Lim, DS; Park, DW; Park, SJ; Park, SW; Seong, IW; Seung, KB; Yang, JY; Yoon, J; Yun, SC | 1 |
| Erl, A; Hoppmann, P; Kastrati, A; Koch, W; Mehilli, J; Schömig, A; Tiroch, K; Türk, S | 1 |
| Cho, YK; Han, SW; Hur, SH; Kim, DI; Kim, DK; Kim, DS; Kim, H; Kim, KB; Kim, YJ; Kim, YN; Nam, CW; Park, HJ; Park, JS; Shim, BS; Shin, DG; Yang, TH | 1 |
| Chen, J; Gao, R; Gao, Z; Li, J; Qiao, S; Qin, X; Wu, Y; Xu, B; Yang, Y; Yuan, J | 1 |
| Ahmar, W; Malaiapan, Y; Meredith, IT; Prasad, SB | 1 |
| Bates, ER | 1 |
| Daemen, J; Garcia-Garcia, H; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R | 1 |
| Almonacid, A; Kirtane, A; Leon, MB; Mauri, L; McLaurin, B; O'Shaughnessy, C; Overlie, P; Popma, JJ | 1 |
| Baim, DS; Cox, DA; Dawkins, KD; Ellis, SG; Forman, DE; Joshi, AA; Lasala, JM; Ormiston, JA; Stone, GW; Turco, MA; Wei, JY | 1 |
| Carrie, D; Chevalier, B; Detiege, D; Garcia, E; Hauptmann, KE; Koolen, J; Morice, MC; Nagai, H; Park, SJ; Paunovic, D; Schuler, G; Serruys, PW; Silber, S; Suryapranata, H; van Es, GA; Wijns, W | 1 |
| Cook, S; Wenaweser, P | 1 |
| Bachinsky, WB; Baim, DS; Baran, K; Breall, JA; Cox, DA; Dawkins, KD; Dobies, D; Lasala, JM; Lewis, DH; Mascioli, SR; Rogers, EW; Song, A; Starzyk, RM | 1 |
| Dippon, J; Gawaz, M; Geisler, T; Göhring-Frischholz, K; Haase, KK; Hartmann, U; Herdeg, C; May, AE; Nusser, T; Wöhrle, J; Zürn, C | 1 |
| Beijk, MA; Claessen, BE; Henriques, JP; Legrand, V; Manari, A; Miquel-Hebert, K; Piek, JJ; Ruzyllo, W; Serruys, PW; Suttorp, MJ; Tijssen, JG; Varenne, O; Veldhof, S | 1 |
| Gruene, S; Huegl, B; Korn, HV; Lauer, B; Ohlow, MA; Petek, O; Schulte, W; Wagner, A; Wassmer, G; Yu, J | 1 |
| Austin, PC; Blackhouse, G; Chiu, M; Cohen, EA; Goeree, R; Ko, DT; Tu, JV; Velianou, JL | 1 |
| Buller, NP; Chue, CD; Doshi, SN; Epstein, AC; Ludman, PF; Routledge, HC; Townend, JN | 1 |
| Aronow, WS; Kakar, P; Kalapatapu, K; Lal, P; Mohan, D; Monsen, CE; Palaniswamy, C; Pucillo, AL; Singh, T; Sorbera, C; Sukhija, R; Weiss, MB | 1 |
| Boland, J; Dorange, C; Garcia, E; Garg, S; Huber, K; Miquel-Hébert, K; Onuma, Y; Serruys, P; Sudhir, K; te Riele, JA; Veldhof, S | 1 |
| Anstrom, KJ; Cutlip, DE; Douglas, JS; Eisenstein, EL; Kandzari, DE; Kirtane, AJ; Leon, MB; Mauri, L; McLaurin, BT; Nikolsky, E; O'Shaughnessy, C; Overlie, PA; Popma, JJ; Solomon, SL | 1 |
| Baim, DS; Bergin, PJ; Bowman, TS; Caputo, R; Cox, DA; Ellis, SG; Hermiller, J; Mann, T; O'Shaughnessy, C; Stone, GW; Turco, M | 1 |
| Campos, C; Cano, M; Carballo, M; Costa, JR; Costa, RA; Maldonado, G; Moreira, AC; Pavanello, R; Sousa, A; Sousa, JE | 1 |
| Hermiller, J; Lansky, A; Miquel-Hebert, K; Onuma, Y; Serruys, PW; Seth, A; Sood, P; Stone, GW; Sudhir, K; Veldhof, S; Yu, S | 1 |
| Cassese, S; Chiariello, M; D'Andrea, C; De Rosa, R; Galasso, G; Piccolo, R; Piscione, F | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Kim, SY; Koo, BK; Lee, SP; Park, KW; Shin, DH; Suh, JW; Yeon, TJ | 1 |
| Bestehorn, HP; Buettner, HJ; Comberg, T; Ferenc, M; Gick, M; Kienzle, RP; Neumann, FJ; Werner, KD; Zhao, M | 1 |
| Bacà, M; Ferrante, G; Montone, RA; Niccoli, G | 1 |
| Bharaj, H; Brodie, BR; Doi, H; Guagliumi, G; Kellett, MA; Kubo, T; Lansky, AJ; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Tsujita, K; Witzenbichler, B; Yang, J | 1 |
| Battes, L; Boersma, E; de Boer, S; Magro, M; Onuma, Y; Serruys, PW; Simsek, C; van Domburg, RT | 1 |
| Hillegass, WB | 3 |
| Beqiri, A; Berti, S; Gianetti, J; Palmieri, C; Paradossi, U; Ravani, M; Rizza, A; Trianni, G; Vaghetti, M | 1 |
| Budoff, MJ; Gupta, M | 1 |
| Choi, D; Jang, Y; Kim, J; Kim, JS; Kim, U; Ko, YG; Lee, JM; Son, JW | 1 |
| Kandzari, DE; Lee, MS; Liao, H; Mahmud, E; Tobis, JM; Yang, T | 1 |
| Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Jang, Y; Jeong, MH; Kim, HS; Lee, SH; Park, SJ; Rha, SW; Seong, IW; Seung, KB; Song, YB; Tahk, SJ; Yang, JY; Yoon, JH | 1 |
| Bhatia, R; Ehdaie, A; Favaretto, E; Lee, MS; Tarantini, G; Tobis, J; Xhaxho, J; Yang, T | 1 |
| Allocco, DJ; Curzen, N; Dawkins, KD; Grube, E; Hauptmann, KE; Nickenig, G; Schofer, J | 1 |
| Cao, S; Caputo, R; Cutlip, DE; Doostzadeh, J; Kereiakes, DJ; Lansky, AJ; Mastali, K; Newman, W; Rizvi, A; Simonton, CA; Stone, GW; Sudhir, K; Wang, JC | 1 |
| Ben-Dor, I; Collins, SD; Gaglia, MA; Gonzalez, MA; Lindsay, J; Pichard, AD; Satler, LF; Suddath, WO; Syed, AI; Torguson, R; Waksman, R | 1 |
| Bae, JH; Chae, IH; Chae, JK; Chae, SC; Cho, MC; Cho, Y; Choi, DJ; Chung, WY; Hong, TJ; Hur, SH; Jang, YS; Jeong, KT; Jeong, MH; Kim, DI; Kim, HS; Kim, MJ; Kim, YJ; Lee, MY; Oh, SK; Park, KS; Park, KW; Park, SK; Rha, SW; Seo, WW; Seong, IW; Yang, HM; Yoon, JH | 1 |
| Bhambhani, A; Billinger, M; Cook, S; Hellige, G; Hofmann, A; Jüni, P; Meier, B; Millauer, N; Räber, L; Seiler, C; Togni, M; Urwyler, N; Vogel, R; Wandel, S; Wenaweser, P; Windecker, S | 1 |
| Applegate, R; Cao, S; Doostzadeh, J; Gordon, P; Hermiller, J; Lansky, A; Simonton, C; Stone, G; Su, X; Sudhir, K; Williams, J | 1 |
| Chan, MY; Chen, Z; Lee, CH; Tai, BC; Tan, HC; Tse, HF | 1 |
| Colombo, A; Dawkins, KD; Feldman, TE; Holmes, DR; Kappetein, AP; Leadley, K; Mack, MJ; Mohr, F; Morice, MC; Serruys, PW; Ståhle, E; Torracca, L; van Es, GA | 1 |
| Chong, E; Hou, XM; Liang, S; Poh, KK; Tan, HC | 1 |
| Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Lassen, JF; Madsen, M; Maeng, M; Ravkilde, J; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH | 1 |
| Antoniucci, D; Barbagallo, R; Cera, M; Chieffo, A; Colombo, A; Di Mario, C; Furuichi, S; Godino, C; Goktekin, O; Grube, E; Latib, A; Mueller, R; Parodi, G; Reimers, B; Sangiorgi, GM; Tamburino, C | 1 |
| Allocco, DJ; Dawkins, KD; Grube, E; Lefèvre, T; Ormiston, JA | 1 |
| Agostoni, P; Banerjee, S; Brilakis, ES; Kandzari, DE; Lombardi, WL; Rangan, BV; Saeed, B | 1 |
| Cho, YK; Hong, GR; Hur, SH; Kim, DI; Kim, DK; Kim, DS; Kim, HS; Kim, KB; Kim, U; Kim, YJ; Lee, SH; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH | 1 |
| Cao, H; Chen, YH; Li, J; Liang, D; Liu, Y; Peng, L; Xiao, J; Yan, B; Zhang, H; Zhao, H; Zhou, Z | 1 |
| Akin, I; Bufe, A; Eckardt, L; Kuck, KH; Nienaber, CA; Reinecke, H; Richardt, G; Schneider, S; Senges, J | 1 |
| Bartorelli, AL; Miquel-Hébert, K; Pierson, W; Serruys, PW; Stone, GW; Yu, S | 1 |
| Juwana, YB; Ottervanger, JP; Rasoul, S; Suryapranata, H | 1 |
| Airaksinen, KE; Biancari, F; Billinger, M; Hess, O; Karjalainen, PP; Raeber, L; Ylitalo, A | 1 |
| Chen, LL; Lin, CG; Lin, QF; Luo, YK; Peng, YF; Zhen, XC | 1 |
| Cheng, JM; Eindhoven, J; Garcia-Garcia, HM; Garg, S; Girasis, C; Kukreja, N; Onuma, Y; Piazza, N; Serruys, PW; Valgimigli, M; van Domburg, R | 1 |
| Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
| Chen, JP; Chen, SL; Jiang, Q; Kan, J; Mintz, G; Stone, GW; Sun, X; Xu, B; Xu, Y; Ye, F; Zhang, A; Zhang, J | 1 |
| Aparci, M; Cebeci, BS; Kardesoglu, E; Ozmen, N; Yiginer, O | 1 |
| Alonso, JJ; Alonso-Briales, JH; Ancillo, P; Bethencourt, A; Bosa, F; de Prado, AP; Fernández-Avilés, F; Gimeno, F; López-Messa, J; San Román, JA; Sánchez, PL; Sanchis, J; Santos, I; Sanz, JJ | 1 |
| Brodie, B; Dressler, O; Guagliumi, G; Guo, N; He, Y; Kellett, MA; Lansky, AJ; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Witzenbichler, B; Wu, X; Xu, K | 1 |
| Bae, JH; Cha, KS; Chae, SC; Gwon, HC; Hong, SJ; Hur, SH; Kim, MH; Lim, DS; Park, HS | 1 |
| Cao, J; Fu, L; Qu, F; Sun, D; Xie, R; Zhou, J | 1 |
| Birkmeier, KA; Byrne, RA; Holle, H; Kastrati, A; Kufner, S; Laugwitz, KL; Massberg, S; Mehilli, J; Schömig, A; Schulz, S; Tiroch, K | 1 |
| Antoniucci, D; Bernardi, V; Bettinoti, M; Curotto, V; Delacasa, A; Fernandez-Pereira, C; Mieres, J; Palacios, IF; Rodriguez, AE; Rodriguez-Granillo, AM; Rodriguez-Granillo, G; Rubilar, B; Santaera, O; Tronge, J; Vigo, CF | 1 |
| Li, YL; Lu, WL; Wan, Z; Wang, JH | 1 |
| Ahmed, WH; Mendiz, OA; Thomas, MR | 1 |
| Chen, SL; Chen, YD; Fang, WY; Hu, DY; Kan, J; Kwan, TW; Lin, S; Liu, ZZ; Qian, J; Shan, SJ; Sun, XW; Tian, NL; Wei, M; Yang, S; Ye, F; Yuan, ZB; Zhang, JJ; Zhu, ZS | 1 |
| Chen, YX; Pan, XH; Wang, JA; Xiang, MX; Xu, G | 1 |
| Anthopoulos, PL; Antonelis, I; Gavaliatsis, I; Gavrielatos, G; Ifantis, G; Pappas, LK; Salachas, A | 1 |
| Chae, SC; Cho, MC; Choi, DJ; Jeong, MH; Kim, CH; Kim, HS; Kim, KH; Koo, BK; Lee, SR; Min, HS; Park, BJ; Park, KW; Park, SK; Seong, IW | 1 |
| Cutlip, DE; Kandzari, DE; Leon, MB; Liberman, H; Mauri, L; Moses, J; Nikolsky, E; Patterson, J; Wilson, H | 1 |
| Boersma, E; Gaspersz, MP; Magro, M; Nauta, ST; Onuma, Y; Serruys, PW; Simsek, C; van der Giessen, WJ; van Domburg, RT | 1 |
| Cassese, S; D'Anna, C; De Rosa, R; Galasso, G; Piccolo, R; Piscione, F | 1 |
| Giannopoulos, S; Goudevenos, JA; Kounis, NG | 1 |
| Haraguchi, Y; Hariki, H; Hirata, K; Honjo, T; Inoue, T; Ishida, T; Kawamori, H; Kozuki, A; Nishio, R; Sawada, T; Shinke, T; Shinohara, M; Shite, J; Toh, R | 1 |
| Abdramanov, KA; Batyraliev, TA; Belenkov, IuN; Fettser, DV; Niyazova-Karben, ZA; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Dong, L; Ge, J; Qian, J; Zhang, F | 1 |
| Bongo, AS; Buffon, A; De Servi, S; Lazzero, M; Lupi, A; Navarese, EP; Sansa, M; Serra, A | 1 |
| Park, SJ | 1 |
| Appleby, CE; Clarke, B; Curzen, N; Fath-Ordoubadi, F; Khattar, RS; Morgan, K; Neyses, L | 1 |
| Hayashi, Y; Hirao, H; Kawase, T; Masaoka, Y; Mito, S; Motoda, C; Muraoka, Y; Okimoto, T; Otsuka, M; Takeda, R; Tamekiyo, H; Toyofuku, M; Ueda, H; Watanabe, N | 1 |
| Bezerra, HG; Costa, MA; Cristea, E; Dressler, O; Guagliumi, G; Lansky, AJ; Lortkipanidze, N; Maehara, A; Matiashvili, A; Mehran, R; Mihalcsik, L; Mintz, GS; Musumeci, G; Parise, H; Sirbu, V; Stone, GW; Suzuki, N; Trivisonno, A; Valsecchi, O | 1 |
| Baim, DS; Colombo, A; Cox, DA; Ellis, SG; Gerber, RT; Joshi, AA; Lasala, JM; Mikhail, GW; Ormiston, JA; Stone, GW; Turco, MA | 1 |
| Charnigo, R; Moliterno, DJ; Ziada, KM | 1 |
| Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, MS; Slagboom, T; Suttorp, MJ; Tijssen, JG; van Etten, J; Vink, MA | 1 |
| Bensimhon, A; Brodie, B; Cooper, M; Fleishman, N; Hansen, C; Kissling, G; McAlhany, C; Milks, S; Pokharel, Y; Stuckey, T | 1 |
| Kang, SJ; Kim, PJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SH; Park, DW; Park, HJ; Park, SJ; Park, SW; Seung, KB | 1 |
| Cannon, LA; Dawkins, KD; Kellett, MA; Kereiakes, DJ; Lee, TC; Mann, T; McGarry, T; Mishkel, GJ; Mooney, MR; Orlow, S; Popma, JJ; Ring, ME; Stuckey, TD; Underwood, P; Wilson, BH | 1 |
| Abdel-karim, AR; Addo, T; Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Haagen, D; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Rangan, BV; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Voudris, VV | 1 |
| Butman, SM | 1 |
| Brodie, BR; Dudek, D; Guagliumi, G; Hartmann, F; Hood, KL; Kornowski, R; Lansky, AJ; Mehran, R; Nikolsky, E; Parise, H; Peruga, JZ; Stone, GW; Witzenbichler, B; Wöhrle, J | 1 |
| Takagi, H; Umemoto, T | 1 |
| Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Jeong, JO; Kang, SJ; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC | 1 |
| Brodie, BR; Caixeta, A; Cristea, E; Dangas, GD; Dudek, D; Guagliumi, G; Lansky, AJ; Mehran, R; Möeckel, M; Parise, H; Peruga, JZ; Stone, GW; Witzenbichler, B | 1 |
| Bowman, TS; Brilakis, ES; Cox, DA; Dawkins, KD; Lasala, JM; Starzyk, RM | 1 |
| Ben-Dor, I; Delhaye, C; Gaglia, MA; Gonzalez, MA; Kent, KM; Mahmoudi, M; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Wakabayashi, K; Waksman, R; Xue, Z | 1 |
| Dänschel, W; Desch, S; Erbs, S; Gielen, S; Kleinertz, K; Lauer, B; Linke, A; Möbius-Winkler, S; Schloma, D; Schuler, G; Thiele, H; Yu, J | 1 |
| Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Hong, KP; Lee, SH; Park, JE; Ryu, DR; Song, PS; Song, YB | 1 |
| Baan, J; Beijk, MA; de Winter, RJ; Henriques, JP; Klomp, M; Koch, KT; Piek, JJ; Tijssen, JG; van Geloven, N; Vis, MM | 1 |
| De Jaegere, P; Deckers, JW; Magro, M; Nauta, ST; Regar, E; Serruys, PW; Simsek, C; Van Der Giessen, WJ; Van Domburg, RT; Van Geuns, RJ; Van Mieghem, NM | 1 |
| Fahy, M; Kedhi, E; Kereiakes, DJ; Parise, H; Serruys, PW; Smits, PC; Stone, GW | 1 |
| Bleuit, JS; Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Popma, JJ; Russell, ME; Stone, GW; Uchida, T | 1 |
| Brodie, BR; Dangas, G; Dudek, D; Fahy, M; Gersh, BJ; Guagliumi, G; Hartmann, F; Kornowski, R; Mehran, R; Parise, H; Peruga, JZ; Pocock, SJ; Stone, GW; Witzenbichler, B; Wong, SC | 1 |
| Bowman, TS; Cox, DA; Dawkins, KD; Lasala, JM; Lee, MS; Starzyk, RM; Yang, T | 1 |
| Dirksen, MT; Ijsselmuiden, AJ; Kiemeneij, F; Laarman, GJ; Patterson, MS; Slagboom, T; Suttorp, MJ; Tijssen, JG; van Geloven, N; Vink, MA | 1 |
| Brener, SJ; Cristea, E; Kirtane, AJ; Mehran, R; Stone, GW | 1 |
| Ahn, Y; Bae, JH; Chae, IH; Chae, JK; Chae, SC; Cho, JG; Cho, MC; Choi, D; Chung, WS; Hong, TJ; Hur, SH; Jang, YS; Jeong, MH; Kang, JC; Kim, CJ; Kim, YJ; Lee, MG; Park, JC; Park, SJ; Rha, SW; Rhew, JY; Seong, IW; Seung, KB; Yoon, J | 1 |
| Cannon, LA; Dawkins, KD; Kereiakes, DJ; Mann, T; McGarry, T; Mishkel, GJ; Ormiston, JA; Turco, MA; Underwood, P; Wang, H | 1 |
| Fujii, K; Hirayama, H; Iwabuchi, M; Kotani, J; Kozuma, K; Muramatsu, T; Nakamura, M; Saito, S; Uchida, T | 1 |
| Bates, ER; Menees, DS | 1 |
| Flores, AI; Mehta, S; Oliveros, E | 1 |
| Boersma, E; Daemen, J; Gaspersz, M; Magro, M; Nauta, S; Onuma, Y; Serruys, P; Simsek, C; van der Giessen, W; van Domburg, R; van Geuns, RJ | 1 |
| Amoroso, G; Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, MS; Slagboom, T; Suttorp, MJ; Tijssen, JG; Van Der Schaaf, RJ; Van Nooijen, FC; Vink, MA | 1 |
| Claessen, BE; Dangas, G; Fahy, M; Goto, K; Guagliumi, G; Kornowski, R; Lansky, AJ; Mehran, R; Nikolsky, E; Parise, H; Stone, GW; Witzenbichler, B | 1 |
| Agnifili, M; Bedogni, F; Brambilla, N; Lanotte, S; Latini, RA; Laudisa, ML; Pizzocri, S; Testa, L | 1 |
| Caputo, R; Farhat, N; Hermiller, JB; Koo, K; Lansky, AJ; Sanz, M; Smith, RS; Sood, P; Stone, GW; Sudhir, K; Williams, JE; Yaqub, M | 1 |
| Ahn, T; Bae, JH; Choi, JW; Han, SH; Hur, SH; Jang, Y; Jeong, MH; Kang, WC; Kim, BO; Kim, DI; Lee, K; Oh, SK; Park, JS; Rha, SW; Shin, EK; Yoon, JH | 1 |
| Agostoni, P; Belkacemi, A; Sangiorgi, G; Silber, S; Stahnke, S; Stella, PR; Torguson, R; von Strandmann, RP; Waksman, R | 1 |
| Blanchard, D; Brunel, P; Carrié, D; Darremont, O; Dibie, A; Eltchaninoff, H; Fajadet, J; Gilard, M; Koning, R; Lablanche, JM; Lefèvre, T; Moynagh, A; Silvestri, M | 1 |
| Buja, P; Favaretto, E; Iliceto, S; Isabella, G; Lanzellotti, D; Napodano, M; Panfili, M; Tarantini, G | 1 |
| Dietz, U; Hehrlein, C; Hoffmann, E; Naber, C; Richardt, G; Schneider, H; Wiemer, M | 1 |
| Cortese, B | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Choi, SH; Gwon, HC; Hahn, JY; Kang, HJ; Kang, SH; Kim, HS; Kim, JH; Koo, BK; Lee, HY; Lim, WH; Park, KW; Seo, JW; Song, YB; Youn, TJ | 1 |
| Claessen, BE; Cristea, E; Fahy, M; Kedhi, E; Kereiakes, DJ; Lansky, AJ; Parise, H; Serruys, PW; Simonton, CA; Smits, PC; Sood, P; Stone, GW; Sudhir, K | 1 |
| Cheong, SS; Cho, BR; Kim, HS; Lee, K; Lee, NH; Lee, SG; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
| Chong, AY; Dwivedi, G; Steed, R | 1 |
| Abdel-Latif, A; Brodie, B; Charnigo, R; Matnani, R; Moliterno, DJ; Wallace, EL; Ziada, KM | 1 |
| Goedhart, D; Gomes, M; Joesoef, KS; Kedhi, E; McFadden, E; Smits, PC; Wassing, J | 1 |
| Airaksinen, KE; Karjalainen, PP; Lehtinen, T; Ylitalo, A | 1 |
| Akkerhuis, KM; Boersma, E; Daemen, J; de Boer, SP; de Jaegere, P; Marcolino, MS; Serruys, PW; Simsek, C; van Domburg, RT; van Geuns, RJ | 1 |
| Airaksinen, KE; Karjalainen, PP; Kervinen, K; Nammas, W; Niemelä, M; Nyman, K; Pietilä, M; Sia, J; Tuomainen, PO; Ylitalo, A | 2 |
| Shammas, NW | 1 |
| Bae, JH; Hur, SH; Jang, Y; Jeong, MH; Kim, HS; Park, JS; Park, K; Park, KW; Rha, SW; Yoon, JH | 1 |
| Aghajani, H; Alidoosti, M; Amirzadegan, AR; Hajizeinali, AM; Hakki-Kazazi, E; Kassaian, SE; Nematipour, E; Poorhosseini, H; Salarifar, M; Shafiee, N; Sheikhfathollahi, M; Tokaldany, ML | 1 |
| Adriaenssens, T; Agostoni, P; Belkacemi, A; Dens, J; Doevendans, P; Dubois, C; Naber, C; Nathoe, H; Stella, PR; van Belle, E | 1 |
| Ahn, JM; Cho, SW; Choo, SJ; Chung, CH; Han, S; Hwang, KW; Jung, SH; Kang, SJ; Kim, WJ; Kim, YG; Kim, YH; Kim, YR; Lee, CH; Lee, CW; Lee, JW; Lee, JY; Lee, SW; Lee, WS; Park, DW; Park, GM; Park, SJ; Park, SW; Song, HG; Sun, BJ | 1 |
| Abdel-Wahab, M; Baev, R; Dieker, P; Geist, V; Kassner, G; Khattab, AA; Richardt, G; Sulimov, D; Toelg, R | 1 |
| Brodie, B; Cristea, E; Dressler, O; Guagliumi, G; Guo, N; Kubo, T; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Witzenbichler, B; Wu, X; Xu, K; Yang, J | 1 |
| Applegate, RJ; Cao, S; Cutlip, DE; Hattori, K; Hermiller, JB; Hou, L; Kereiakes, DJ; Pervaiz, MH; Sood, P; Stone, GW; Su, X; Sudhir, K; Wang, J; Yaqub, M | 1 |
| Borghesi, M; Campo, G; Cangiano, E; Castriota, F; Cavazza, C; Colombo, F; Ferrari, R; Frangione, A; Fucà, G; Kubbajeh, M; Marchesini, J; Minarelli, M; Monti, M; Parrinello, G; Percoco, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P | 1 |
| Brodie, BR; Chantziara, V; Claessen, BE; Dangas, GD; Guagliumi, G; Hakim, D; Henriques, JP; Leon, S; Mehran, R; Sanidas, EA; Stone, GW; Tijssen, JG; Witkowski, A; Witzenbichler, B; Wöhrle, J; Xu, K; Zmudka, K | 1 |
| Barbash, IM; Hauville, C; Laynez, A; Pakala, R; Pichard, AD; Sardi, G; Satler, LF; Torguson, R; Waksman, R; Xue, Z | 1 |
| Agostoni, P; Belkacemi, A; Doevendans, PA; Nathoe, HM; Politi, L; Sangiorgi, GM; Shao, C; Stella, PR; Van Belle, E; Voskuil, M; Wildbergh, T | 1 |
| Werner, GS; Wöhrle, J | 1 |
| White, HD | 1 |
| Chechi, T; Cortese, G; De Luca, G; Di Lorenzo, E; Díaz de la Llera, LS; Dirksen, MT; Kaiser, C; Kelbaek, H; Musto, C; Pasceri, V; Schalij, M; Spaulding, C; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; van der Hoeven, B; Vink, MA; Violini, R | 1 |
| Kalidoss, L; Sankardas, MA; Subban, V | 1 |
| Applegate, RJ; Cao, S; Ferguson, JM; Gordon, PC; Hermiller, JB; Rizvi, A; Smith, RS; Sood, P; Stone, GW; Sudhir, K; Wang, J; Yaqub, M | 1 |
| Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE | 1 |
| Ishikawa, T; Miyamoto, T; Murakami, A; Mutoh, M; Nakano, Y; Nakata, K; Suzuki, T; Yoshimura, M | 1 |
| Brener, SJ; Cristea, E; Fahy, M; Lansky, AJ; Mehran, R; Stone, GW | 1 |
| Jang, SJ; Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
| Buja, P; Facchin, M; Frigo, AC; Meliga, E; Menozzi, A; Musumeci, G; Saia, F; Sardella, G; Tamburino, C; Tarantini, G | 1 |
| Batchelor, WB; Ellis, SG; Joshi, AA; Ormiston, JA; Stone, GW; Underwood, PL; Wang, H | 1 |
| Darremont, O; Garot, P; Lefèvre, T; Leymarie, JL; Louvard, Y; Meftout, B; Morice, MC; Moynagh, A; Mylotte, D; Silvestri, M; Vaquerizo, B | 1 |
| Ishikawa, T; Mutoh, M; Nakano, Y | 1 |
| Fortuna, R; Ho, PC; Lee, AC | 1 |
| Dang, Q; Gao, L; Gou, LX; Jin, Z; Li, YJ | 1 |
| Buszman, PE; Buszman, PP; Drzewiecki, J; Granada, JF; Kaluza, GL; Kozlowski, M; Milewski, K; Orlik, B; Peppas, A; Pruski, M; Trela, B | 1 |
| Ahmed, K; Ahmed, S; Ahn, Y; Chakraborty, R; Cho, MC; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, CJ; Kim, JH; Kim, YJ; Lee, MG; Park, JC; Park, KH; Sim, DS | 1 |
| Arora, R; Bahekar, A; Bajaj, A; Bhuriya, R; Khosla, S; Sethi, A; Singh, PP | 1 |
| Brodie, BR; Chantziara, V; Claessen, BE; Dangas, GD; Guagliumi, G; Henriques, JP; Kikkert, WJ; Mehran, R; Sanidas, EA; Stone, GW; Tijssen, JG; Witkowski, A; Witzenbichler, B; Wöhrle, J; Xu, K; Zmudka, K | 1 |
| Cannon, LA; Charles, O; Dawkins, KD; Hall, JJ; Mann, T; McGarry, T; Mishkel, GJ; Ormiston, JA; Underwood, PL; Webster, MW | 1 |
| Almalla, M; Hoffmann, R; Marx, N; Pross, V; Schröder, JW | 1 |
| Cho, HJ; Kang, DY; Kang, HJ; Kim, HS; Koo, BK; Lee, HY; Park, JB; Park, KW; Yang, HM | 1 |
| Ahn, JM; Kang, SJ; Kim, WJ; Kim, YH; Lee, BK; Lee, CW; Lee, JH; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Seong, IW; Song, HG; Yun, SC | 1 |
| Abdel-Wahab, M; Geist, V; Joachim Büttner, H; Khattab, AA; King, L; Meinertz, T; Neumann, FJ; Richardt, G; Schofer, J; Toelg, R | 1 |
| Ahmed, K; Ahn, Y; Bae, JH; Chae, SC; Cho, KH; Cho, MC; Choi, D; Chung, WS; Hachinohe, D; Hong, TJ; Hong, YJ; Hur, SH; Hwang, SH; Jang, YS; Jeong, MH; Kang, JC; Kim, CJ; Kim, JH; Kim, MC; Kim, YJ; Lee, MG; Park, KH; Park, SJ; Rha, SW; Saito, S; Seong, IW; Seung, KB; Sim, DS | 1 |
| Claessen, BE; Dangas, GD; Mehran, R; Stone, GW; Xu, K | 1 |
| Miquel-Hebert, K; Onuma, Y; Serruys, PW | 1 |
| Hur, SH; Jang, JS; Kim, DI; Kim, DK; Kim, DS; Kim, KB; Kim, U; Kim, YJ; Nam, CW; Park, JS; Seol, SH; Son, JW; Yang, TH | 1 |
| Brodie, BR; Bryniarski, L; Dudek, D; Dziewierz, A; Fahy, M; Kornowski, R; Lansky, AJ; Legutko, J; Mehran, R; Rakowski, T; Stone, GW; Witzenbichler, B | 1 |
| Boura, J; Harjai, KJ; Harjai, N; Kondareddy, S; Orshaw, P; Pinkosky, B | 1 |
| Chaikin, P; Durrleman, S | 1 |
| Kleiman, NS; Nguyen-Ho, P; Verani, MS | 1 |
| Akula, R; Dawkins, F; Hasan, SP; Kamineni, P; Prakasa, K | 1 |
| Bode, C; Schofer, J; Silber, S | 1 |
| Becherini, R; Chechi, T; Comeglio, M; Falai, M; Gensini, GF; Giglioli, C; Lazzeri, C; Margheri, M; Parigi, E; Valente, S; Vittori, G | 1 |
| Lee, CH; Lim, YT; Ong, HY; Tan, HC; Teo, SG | 1 |
| Grover, A; Malhotra, S; Pandhi, P; Shafiq, N; Uboweja, A | 1 |
| Rogers, CD | 1 |
| Katsamakis, CD; Klein, LW; Kozinski, M | 1 |
| Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Ge, L; Gerckens, U; Grube, E; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM; Schmidt, T; Stankovic, G | 1 |
| Cohen, MG; Ohman, EM | 1 |
| Aoki, J; de Feyter, PJ; de Jaegere, PP; Hofma, SH; McFadden, EP; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Valgimigli, M; van der Giessen, WJ; Van Domburg, RT; van Mieghem, CA | 1 |
| Airoldi, F; Chieffo, A; Colombo, A; Corvaja, N; Ge, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM; Tsagalou, E | 1 |
| Guallar, E; Kim, SJ; Kittleson, MM; Needham, DM; Ravindran, BK; Solomon, SS | 1 |
| Albertal, M; Balino, PP; Belardi, JA; Berrocal, D; Cura, F; Fava, C; Grinfeld, L; Mendiz, O; Padilla, L; Pascua, JA; Solioz, G | 1 |
| Ahn, TH; Choi, KR; Han, SH; Kang, WC; Shin, EK | 1 |
| Aoki, J; de Feyter, PJ; de Jaegere, PP; McFadden, EP; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Sonnenschein, K; Tsuchida, K; Valgimigli, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
| Billinger, M; Corti, R; Eberli, FR; Egger, M; Hess, OM; Jüni, P; Lüscher, T; Maier, W; Meier, B; Räber, L; Remondino, A; Roffi, M; Seiler, C; Sütsch, G; Togni, M; Tüller, D; Wenaweser, P; Windecker, S | 1 |
| Dibra, A; Dirschinger, J; Kastrati, A; Mehilli, J; Pache, J; Schömig, A; Schühlen, H; Ulm, K; von Beckerath, N; Wessely, R | 1 |
| Crepin, F; Decoene, C; Fabre, O; Pol, A; Vincentelli, A | 1 |
| Boccuzzi, G; Pagnotta, P; Presbitero, P | 1 |
| Abizaid, A; Missel, E; Sousa, A; Sousa, JE | 1 |
| Abaci, A; Simsek, V; Turkoglu, S | 1 |
| Agostoni, P; Airoldi, F; Biondi-Zoccai, GG; Bonizzoni, E; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; Ge, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM | 1 |
| Dibra, A; Dirschinger, J; Kastrati, A; Mehilli, J; Pache, J; Schömig, A | 1 |
| Lee, CH; Lim, J; Lim, YT; Low, A; Tan, HC | 1 |
| Sabaté, M | 1 |
| Tanabe, K | 1 |
| Ahmad, M; Natarajan, MK; Schwalm, JD; Velianou, JL; Xie, C | 1 |
| Nordmann, A | 1 |
| Chu, WW; Clavijo, LC; Kent, KM; Kuchulakanti, PK; Pichard, AD; Satler, LF; Suddath, WO; Waksman, R; Wang, B | 1 |
| Abizaid, A; Costa, JR; Feres, F | 1 |
| Daly, BD; Dipetrillo, TA; Fernando, HC; Kachnic, LA; Ketchedjian, A; Morelli, DM; Shemin, RJ | 1 |
| Farb, A; Finn, AV; Gold, HK; Joner, M; Kolodgie, FD; Kutys, R; Ladich, E; Mont, EK; Skorija, K; Virmani, R | 1 |
| Gunalingam, B; Henderson, D | 1 |
| Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, M; Rensing, BJ; Slagboom, T; Suttorp, MJ; Tijssen, JG; van der Wieken, LR; van Heerebeek, L | 1 |
| Van de Werf, F | 1 |
| Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Park, KH; Park, SJ; Park, SW | 1 |
| Di Russo, C; Ferraiuolo, G; Loschiavo, P; Musto, C; Palamara, A; Patrizi, R; Rigattieri, S; Silvestri, P | 1 |
| Aurier, E; Benassi, A; Geraci, G; Grilli, R; Guastaroba, P; Manari, A; Marzocchi, A; Piovaccari, G; Saia, F; Sangiorgio, P; Santarelli, A; Tarantino, F; Vecchi, G | 1 |
| Dibra, A; Elezi, S; Kastrati, A; Mehilli, J; Pache, J; Schömig, A; Wessely, R | 1 |
| Bilodeau, L; Cieza, T | 1 |
| Abbott, JD; Kip, KE; Williams, DO | 1 |
| Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC | 1 |
| Anstrom, KJ; Califf, RM; Eisenstein, EL; Harrington, RA; Kandzari, DE; Kong, DF; Kramer, JM; Mark, DB; Matchar, DB; Peterson, ED; Schulman, KA; Shaw, LK; Tuttle, RH | 1 |
| Bolognese, L; Percoco, G; Valgimigli, M | 1 |
| Jneid, H; Maree, AO; Palacios, IF | 1 |
| Bader, F; Brunner-La Rocca, HP; Buser, PT; Hunziker, P; Jeger, R; Kaiser, C; Mueller, C; Osswald, S; Pfisterer, M; Rickenbacher, P | 1 |
| Baz, JA; Bordes, P; de la Torre, JM; Hernandez, JM; Iñiguez, A; Lozano, I; Mainar, V; Mauri, J; Sanmartin, M | 1 |
| Bhatia, V; Kachru, R; Kaul, U | 1 |
| Carbone, G; De Luca, G; Gregorio, G; Maione, A | 1 |
| Applegate, RJ; Baki, TT; Gandhi, SK; Kutcher, MA; Little, WC; Sacrinty, MT; Santos, RM | 2 |
| Ligon, RW; Markwell, SJ; Mishkel, GJ; Moore, AL | 1 |
| Applegate, RJ | 1 |
| Chae, IH; Cho, HJ; Cho, YS; Choi, DJ; Chung, WY; Kang, HJ; Kim, HS; Kim, MS; Koo, BK; Oh, BH; Park, JS; Park, YB; Sohn, DW; Suh, JW; Youn, TJ | 1 |
| Buchbinder, M; Colombo, A; Galassi, AR; Grasso, C; Tamburino, C; Tomasello, SD; Ussia, GP | 1 |
| James, SK; Lagerqvist, B; Lindbäck, J; Nilsson, T; Stenestrand, U; Wallentin, L | 1 |
| Colombo, A; Cutlip, DE; Dawkins, KD; Ellis, SG; Fahy, M; Grube, E; Kirtane, AJ; Leon, MB; Mehran, R; Morice, MC; Moses, JW; Pocock, SJ; Schampaert, E; Schofer, J; Stone, GW | 1 |
| Maisel, WH | 1 |
| Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
| Abrecht, L; Boersma, E; Daemen, J; Hellige, G; Hess, OM; Jüni, P; Kukreja, N; Meier, B; Morger, C; Serruys, PW; Sianos, G; Tsuchida, K; Vaina, S; van Domburg, RT; Wenaweser, P; Windecker, S | 1 |
| Al Suwaidi, J; El-Menyar, AA; Holmes, DR | 1 |
| Daemen, J; de Jaegere, PT; Denollet, J; Erdman, RA; Pedersen, SS; Serruys, PW; van de Sande, M; van Domburg, RT | 1 |
| Bush, CA; Doshi, AA; Magorien, RD; Mazzaferri, EL; Orsini, AR; Schmidt, WT | 1 |
| Burelli, C; Cassin, M; De Biasio, M; Driussi, M; Macor, F; Nicolosi, GL; Vendrametto, F | 1 |
| Daemen, J; de Jaegere, PP; García-García, HM; Kukreja, N; Serruys, PW; Sianos, G; Tanimoto, S; van de Sande, M; van Domburg, RT | 1 |
| Finn, AV; Gold, HK; John, MC; Joner, M; Kolodgie, F; Nakazawa, G; Newell, J; Virmani, R | 1 |
| Di Sciascio, G; Pasceri, V; Patti, G; Pristipino, C; Richichi, G; Speciale, G | 1 |
| Abizaid, AA; Centemero, M; Chaves, A; Costa, Jde R; Feres, F; Mattos, LA; Siqueira, DA; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF | 1 |
| Aubry, P; Benamer, H; Ducrocq, G; Feldman, LJ; Himbert, D; Juliard, JM; Majdoub, MA; Sauguet, A; Steg, PG; Tchetche, D | 1 |
| Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E | 1 |
| Amorn, AM; Cercek, B; Dohad, S; Forrester, JS; Kapoor, N; Kar, S; Kupferwasser, LI; Lee, MS; Makkar, RR; Mirocha, J; Shah, PK | 1 |
| Benoît, A; Berger, A; Goy, JJ; Seydoux, C; Siegenthaler, M; Stauffer, JC | 1 |
| Baldereschi, G; Biondi Zoccai, GG; Chechi, T; Falchetti, E; Giglioli, C; Margheri, M; Spaziani, G; Valente, S; Vecchio, S; Vittori, G | 1 |
| Clark, LT; Hannan, EL; Holmes, DR; Jones, RH; Katz, S; King, SB; Racz, M; Sharma, S; Walford, G | 1 |
| Bystron, M; Cervinka, P; Jakabcin, J; Kala, P; Kvasnak, M; Malý, J; Spacek, R; Veselka, J | 1 |
| Bose, R; Choi, JW; Grayburn, PA; Gupta, G; Kang, MJ; Laible, EA | 1 |
| Allemann, S; Cervinka, P; de Lezo, JS; Diem, P; Dirksen, MT; Goy, JJ; Jüni, P; Kastrati, A; Kelbaek, H; Leon, MB; Meier, B; Menichelli, M; Morice, MC; Nordmann, AJ; Park, SJ; Petronio, AS; Pfisterer, ME; Reichenbach, S; Sabaté, M; Schömig, A; Spaulding, C; Stettler, C; Stone, GW; Suttorp, MJ; Trelle, S; Vermeersch, P; Wandel, S; Windecker, S; Zwahlen, M | 1 |
| Chieffo, A; Colombo, A | 1 |
| Banerjee, S; Berger, PB; Brilakis, ES | 1 |
| Brodie, B; Cheek, B; Duffy, P; Hermiller, J; Humphrey, A; Juk, S; Krainin, F; Laurent, S; Metzger, C; Nussbaum, M; Simonton, CA | 1 |
| Bruskina, O; Ibrahim, M; Iijima, R; Kastrati, A; Markwardt, C; Mehilli, J; Ndrepepa, G; Pache, J; Schömig, A | 1 |
| Di Lorenzo, E; Dibra, A; Goy, JJ; Jüni, P; Kaiser, C; Kastrati, A; Lee, JH; Mehilli, J; Meier, B; Park, SJ; Pfisterer, ME; Schömig, A; Suárez de Lezo, J; Windecker, S; Wu, J | 1 |
| Baek, SH; Choi, KB; Jang, SW; Jung, HO; Kim, HY; Kim, PJ; Lee, DH; Park, CS; Park, HJ; Seung, KB | 1 |
| Büttner, HJ; Neumann, FJ | 1 |
| de Vries, ST; Fokkert, MJ; Maas, AH; Nadal, F; Niella, M; Slingerland, RJ; van 't Hof, AW; van Enst, GC | 1 |
| Kang, HJ; Kim, HS; Kim, YS; Koo, BK; Lee, HY; Oh, BH; Park, KW; Park, YB; Sohn, DW | 1 |
| Pocock, SJ | 1 |
| Aoki, J; Collins, M; Dangas, GD; Frankin-Bond, T; Kim, YH; Kimura, M; Kirtane, AJ; Kreps, EM; Lansky, AJ; Leon, MB; Mehran, R; Morales, A; Moses, JW; Moussa, I; Stone, GW; Weisz, G | 1 |
| Collins, MB; Dangas, G; Fahy, M; Gray, WA; Kim, YH; Kirtane, AJ; Kodali, SK; Lansky, AJ; Leon, MB; Mehran, R; Moses, JW; Moussa, I; Pucelikova, T; Stone, GW; Weisz, G | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Chung, JW; Chung, WY; Oh, BH; Park, KW; Park, YB; Yeon, TJ | 1 |
| Aarøe, J; Abildgaard, U; Abildstrøm, SZ; Andersen, HR; Bligaard, N; Bøtker, HE; Engstrøm, T; Galatius, S; Galløe, AM; Hansen, PR; Jensen, JS; Junker, A; Kelbaek, H; Kristensen, SD; Krusell, LR; Lassen, JF; Madsen, JK; Rasmussen, K; Ravkilde, J; Saunamäki, K; Stephansen, GB; Thayssen, P; Thuesen, L | 1 |
| Moliterno, DJ; Mukherjee, D | 1 |
| Batyraliev, TA; Pershukov, IV | 1 |
| Ahn, YK; Bae, JH; Chae, JK; Chae, SC; Cho, MC; Hong, TJ; Hur, SH; Jang, YS; Jeong, MH; Kim, CJ; Kim, YJ; Lee, SR; Park, SJ; Rha, SW; Rhew, JY; Seong, IW | 1 |
| Jobe, RL; Mann, JT; Saylors, EK; Schneider, JE; Wood, FO | 1 |
| Colombo, A | 1 |
| Alfonso, F; Botas, J; de la Torre-Hernández, JM; Diarte, JA; Elizaga, J; Gomez-Jaume, A; Hernández, F; Hernández, JM; Larman, M; Lopez-Minguez, JR; Lozano, I; Mauri, J; Nodar, JM; Perez de Prado, A; Pinar, E; Rodríguez-Collado, J; Rumoroso, JR; Sanchis, J; Sanmartin, M; Vazquez, JM | 1 |
| Bavry, AA; Bhatt, DL; Helton, TJ; Kamdar, AR; Kumbhani, DJ | 1 |
| Abugattás-de Torres, JP; Aldama-López, G; Calviño-Santos, R; Castro-Beiras, A; Flores-Ríos, X; Marzoa-Rivas, R; Piñón-Esteban, P; Salgado-Fernández, J; Vázquez-González, N; Vázquez-Rodríguez, JM | 1 |
| Cho, Y; Choi, SW; Jeong, JO; Kim, HS; Ko, JK; Lee, JH; Lee, N; Lee, SW; Park, JH; Rhee, KS; Seong, IW | 1 |
| Cutlip, DE; Farhat, N; Fitzgerald, PJ; Hermiller, JB; Lansky, AJ; Mahaffey, KW; Midei, M; Newman, W; Sanz, M; Sood, P; Stone, GW; Su, X; Williams, J | 1 |
| Böhm, M; Maack, C; Maier, LS; Ritter, O | 1 |
| Adams, J; Arbuck, SG; Christian, M; Gibbs, H; McGuire, W; Oakes, M; Reed, E; Rowinsky, E; Strauss, H; Suffness, M | 1 |
| Kasimis, B; Loehrer, PJ; McLeod, D; Roth, BJ; Wilding, G; Yeap, BY | 1 |
| Hekmat, E | 1 |
| Karp, SJ; Laher, S | 1 |
| Colombo, A; Liistro, F | 1 |
| Albain, KS; Clark, JI; Fisher, S; Hantel, A; Kancharla, K; Millbrandt, L; Panganiban, J; Qamar, R | 1 |
| Christian, MC; Donehower, RC; Fisherman, JS; Guarnieri, T; McGuire, WP; Rowinsky, EK | 1 |
55 review(s) available for paclitaxel and Cardiovascular Stroke
| Article | Year |
|---|---|
Long-term (2-5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis.
Topics: Antineoplastic Agents; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome | 2017 |
Long-term Outcomes of Paclitaxel-Eluting Versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention: AMeta-Analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cause of Death; Coronary Artery Disease; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome | 2017 |
DES the year in review: controversies.
Topics: Biocompatible Materials; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Diabetes Complications; Disease-Free Survival; Drug-Eluting Stents; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Postoperative Complications; Sirolimus; Thrombolytic Therapy; Treatment Outcome | 2013 |
Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
Topics: Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators | 2013 |
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of P
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Topics: Cardiovascular Agents; Chromium Alloys; Coated Materials, Biocompatible; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2014 |
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
Topics: Anti-Infective Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2013 |
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.
Topics: Absorbable Implants; Bayes Theorem; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents; Tubulin Modulators | 2014 |
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation.
Topics: Aged; Angioplasty; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome | 2014 |
Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
Topics: Coronary Artery Bypass; Diabetes Complications; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Humans; Intention to Treat Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Randomized Controlled Trials as Topic; Reoperation; Sirolimus; Stroke; Survival Analysis; Treatment Outcome | 2014 |
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.
Topics: Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Thrombosis; Time Factors | 2015 |
Drug-coated balloon angioplasty for drug-eluting stent restenosis: insight from randomized controlled trials.
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Drug-Eluting Stents; Humans; Incidence; Mortality; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Randomized Controlled Trials as Topic; Tubulin Modulators | 2014 |
[A simple but very complicated angioplasty: management of coronary artery perforation and dual antiplatelet therapy. A case report and literature review].
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Cardiac Tamponade; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Everolimus; Heparin; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Reoperation; Sirolimus; Thrombosis; Treatment Outcome | 2015 |
A mixed treatment comparison for short- and long-term outcomes of bare-metal and drug-eluting coronary stents.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Death; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2016 |
Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.
Topics: Antineoplastic Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention | 2016 |
Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials.
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Humans; Metals; Myocardial Infarction; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome | 2016 |
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
Topics: Aged; Antineoplastic Agents, Phytogenic; Diabetic Angiopathies; Drug-Eluting Stents; Electrocardiography; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2009 |
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials.
Topics: Coronary Angiography; Death; Drug-Eluting Stents; Equipment Design; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Patient Selection; Randomized Controlled Trials as Topic; Recurrence; Risk; Sirolimus; Thrombosis; Treatment Outcome | 2009 |
Drug-eluting stents for the treatment of acute myocardial infarction: the view to the HORIZONS.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Sirolimus | 2010 |
A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Least-Squares Analysis; Metals; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Predictive value of C-reactive protein after drug-eluting stent implantation.
Topics: Angioplasty, Balloon, Coronary; Atherosclerosis; C-Reactive Protein; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Inflammation; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prognosis; Sirolimus | 2010 |
Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.
Topics: Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Incidence; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Saphenous Vein; Sirolimus; Treatment Outcome; United States | 2010 |
Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Coronary Restenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Treatment Outcome | 2010 |
Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Paclitaxel; Risk Factors; Titanium; Treatment Outcome | 2010 |
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Comparison of sirolimus- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
Topics: Angioplasty, Balloon, Coronary; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Incidence; Myocardial Infarction; Odds Ratio; Paclitaxel; Sirolimus; Statistics as Topic | 2010 |
A meta-analysis of randomized trials on clinical outcomes of paclitaxel-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction patients.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Electrocardiography; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Treatment Outcome | 2010 |
Sirolimus- versus paclitaxel-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Tubulin Modulators | 2011 |
Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome; Tubulin Modulators | 2011 |
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients.
Topics: Aged; Aged, 80 and over; Angioplasty; Bias; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Regression Analysis; Saphenous Vein; Sirolimus; Stents; Treatment Outcome | 2011 |
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis.
Topics: Chromium Alloys; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tubulin Modulators | 2011 |
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Heart Conduction System; Humans; Metals; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2012 |
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Heart Conduction System; Humans; Incidence; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Paclitaxel; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors | 2012 |
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trials.
Topics: Coated Materials, Biocompatible; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Phosphorylcholine; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome | 2012 |
Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
Topics: Administration, Topical; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Brachytherapy; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2004 |
A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.
Topics: Cell Proliferation; Coronary Restenosis; Coronary Stenosis; Death, Sudden, Cardiac; Drug Implants; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome; Tunica Intima | 2005 |
Drug-eluting stents: clinical perspectives on drug and design differences.
Topics: Blood Vessel Prosthesis Implantation; Cell Cycle; Coated Materials, Biocompatible; Coronary Artery Disease; Drug Design; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Prosthesis Design; Stents | 2005 |
The efficacy of sirolimus- and paclitaxel-eluting stents: a meta-analysis of randomized controlled trials.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Sex Factors; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2005 |
Drug eluting stents in acute myocardial infarction.
Topics: Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis | 2005 |
[Technical evolution of the stent].
Topics: Angina, Unstable; Animals; Clinical Trials as Topic; Coronary Restenosis; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Prognosis; Sirolimus; Stents; Syndrome | 2006 |
[Drug-eluting stents: do they keep their promises?].
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Mortality; Myocardial Infarction; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Time Factors | 2006 |
Very late thrombosis after drug-eluting stents.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Time Factors; Ultrasonography, Interventional | 2006 |
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2007 |
Left main coronary artery stenosis: state-of-the-art.
Topics: Aged; Biomarkers; C-Reactive Protein; Catheter Ablation; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Echocardiography, Transesophageal; Exercise Test; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thallium Radioisotopes; Tomography, X-Ray Computed; Treatment Outcome; Tubulin Modulators | 2007 |
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
Topics: Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Risk; Sirolimus; Stents; Survival Analysis; Thrombosis; Treatment Outcome; Tubulin Modulators | 2007 |
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Topics: Anti-Bacterial Agents; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2007 |
Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Drug Implants; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Saphenous Vein; Sirolimus; Stents; Treatment Outcome | 2007 |
The risk of drug-eluting stent thrombosis with noncardiac surgery.
Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Coated Materials, Biocompatible; Coronary Disease; Endothelium, Vascular; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Surgical Procedures, Operative; Time Factors | 2007 |
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
Topics: Aged; Blood Vessel Prosthesis; Comorbidity; Coronary Artery Disease; Coronary Thrombosis; Drug Delivery Systems; Global Health; Humans; Immunosuppressive Agents; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; Stents; Survival Analysis; Treatment Outcome; Tubulin Modulators | 2007 |
[Drug-eluting stent thrombosis and its pharmacological prevention].
Topics: Aspirin; Clopidogrel; Death, Sudden, Cardiac; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Incidence; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Terminology as Topic; Thrombosis; Ticlopidine; Turkey | 2007 |
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2008 |
A reassessment of cardiac toxicity associated with Taxol.
Topics: Animals; Arrhythmias, Cardiac; Female; Heart Diseases; Humans; Myocardial Infarction; Ovarian Neoplasms; Paclitaxel; Polyethylene Glycols | 1993 |
154 trial(s) available for paclitaxel and Cardiovascular Stroke
| Article | Year |
|---|---|
Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Drug-Eluting Stents; Feasibility Studies; Fractional Flow Reserve, Myocardial; Humans; Myocardial Infarction; Paclitaxel; Treatment Outcome | 2022 |
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Topics: Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Treatment Outcome | 2023 |
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
Topics: Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Risk Factors; Treatment Outcome; Vascular Diseases | 2023 |
Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Myocardial Infarction; Oxaliplatin; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur | 2021 |
A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents; Treatment Outcome | 2022 |
gender-specific outcome after paclitaxel-eluting stent implantation in japanese patients with coronary artery disease--sub-analysis of the Japan TAXUS Express2 post-marketing survey.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Asian People; Death; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Registries; Sex Characteristics; Sex Factors; Time Factors | 2013 |
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).
Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Double-Blind Method; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Failure; Time Factors; Ultrasonography, Interventional; United States | 2013 |
The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent.
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2013 |
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
Topics: Aged; Antibodies; Antigens, CD34; Asia; Australia; Brazil; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Endothelial Cells; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Stem Cells; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2013 |
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.
Topics: Aged; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; New Zealand; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2013 |
Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antithrombins; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Percutaneous Coronary Intervention; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2013 |
Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial).
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Thrombosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2014 |
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Feasibility Studies; Female; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Sirolimus; Time Factors; Treatment Outcome | 2013 |
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patient
Topics: Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Humans; Kaplan-Meier Estimate; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2013 |
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment
Topics: Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Italy; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardi
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.
Topics: Aged; Antineoplastic Agents; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Sirolimus | 2014 |
Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Percutaneous Coronary Intervention; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2014 |
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Germany; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Retreatment; Stents; Time Factors; Treatment Outcome; Vascular Access Devices | 2015 |
Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Treatment Outcome | 2014 |
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Internationality; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Thiophenes; Time Factors; Treatment Outcome | 2015 |
Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Antithrombins; Coronary Angiography; Coronary Restenosis; Disease Progression; Drug-Eluting Stents; Electrocardiography; Female; Hemorrhage; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prognosis; Recombinant Proteins; Reoperation | 2015 |
Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.
Topics: Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Smoking; Stroke; Treatment Outcome | 2015 |
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Car
Topics: Aged; Biomarkers; Cardiovascular Agents; Combined Modality Therapy; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Utilization; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Treatment Outcome | 2015 |
Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
Topics: Cardiovascular Agents; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Treatment Outcome | 2015 |
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revasculariza
Topics: Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome | 2015 |
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents | 2015 |
Paclitaxel-coated balloon plus bare-metal stent for de-novo coronary artery disease: final 5-year results of a randomized prospective multicenter trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Artery Disease; Disease-Free Survival; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Single-Blind Method; Stents; Treatment Outcome; Tubulin Modulators | 2016 |
Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
Topics: Aged; Atherectomy, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; Vascular Calcification | 2016 |
Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Recurrence | 2015 |
DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; France; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome | 2015 |
Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
Topics: Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; China; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome | 2016 |
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
Topics: Age Factors; Aged; Antineoplastic Agents, Phytogenic; Aspirin; Diabetes Mellitus; Drug-Eluting Stents; Female; Hemorrhage; Humans; Ischemia; Linear Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Risk Assessment; Risk Factors; Smoking; Thrombosis; Time Factors | 2016 |
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
Topics: Coronary Restenosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2016 |
Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Topics: Aged; Canada; Cardiovascular Agents; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Saphenous Vein; Severity of Illness Index; Time Factors; Treatment Outcome; Vascular Patency | 2016 |
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Treatment Outcome; Young Adult | 2017 |
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Topics: Aged; Brachytherapy; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Risk Factors; Treatment Outcome; Tubulin Modulators | 2008 |
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Risk Factors; Thrombosis; Titanium; Treatment Outcome | 2008 |
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel | 2008 |
[SORT OUT II--a randomized study of drug-eluting coronary stents--secondary publication].
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Sirolimus; Treatment Outcome | 2009 |
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Retreatment; Risk; Stents; Sweden | 2009 |
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Incidence; Male; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Ticlopidine; Tubulin Modulators | 2009 |
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
Topics: Aged; Angioplasty, Balloon, Coronary; Asia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; North America; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Time Factors; Treatment Outcome | 2008 |
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Women's Health | 2009 |
The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Double-Blind Method; Drug-Eluting Stents; Humans; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Recurrence; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Female; Health Status Indicators; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Sirolimus; Survival Analysis | 2009 |
Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Product Surveillance, Postmarketing; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Time Factors; Treatment Outcome; United States | 2009 |
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Thrombosis; Time Factors; Titanium; Treatment Outcome; Tubulin Modulators | 2009 |
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators | 2009 |
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Graft Occlusion, Vascular; Greece; Humans; Metals; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Saphenous Vein; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial.
Topics: Angioplasty, Balloon, Coronary; Cause of Death; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Tubulin Modulators | 2011 |
Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Secondary Prevention; Stents; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2010 |
Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sirolimus; Ticlopidine | 2009 |
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
Topics: Angioplasty, Balloon, Coronary; Asia; Australia; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Assessment; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima | 2009 |
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; New Zealand; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial).
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome | 2009 |
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic End
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Health Care Costs; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Models, Economic; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Quality of Life; Quality-Adjusted Life Years; Risk Assessment; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2009 |
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction.
Topics: Adult; Aged; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Bridging; Myocardial Infarction; Paclitaxel; Stents; Tunica Intima; Ultrasonography, Interventional | 2010 |
Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2010 |
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; England; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Glycoprotein GPIIb-IIIa Complex; Retreatment; Single-Blind Method; Sirolimus; Thrombosis; Treatment Failure | 2010 |
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Creatine Kinase, MB Form; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2010 |
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and C
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Endpoint Determination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Stroke; Treatment Outcome | 2010 |
Eighteen-month clinical safety and efficacy outcomes of sirolimus-, paclitaxel- and zotarolimus-drug eluting stents in diabetic patients undergoing percutaneous coronary intervention for complex coronary artery stenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Survival Analysis; Treatment Outcome | 2010 |
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Choice of stenting strategy in true coronary artery bifurcation lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial.
Topics: Angioplasty; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization a
Topics: Aged; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prospective Studies; Risk Factors; Stents; Thrombosis; Treatment Outcome; Ultrasonography, Interventional | 2010 |
Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: prospective randomized multicenter trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Argentina; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Glycocalyx; Humans; Kaplan-Meier Estimate; Lactic Acid; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2010 |
Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial In
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Prospective Studies; Tomography, Optical Coherence; Tubulin Modulators | 2011 |
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Metals; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cilostazol; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Tetrazoles | 2011 |
A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium Compounds; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Equipment Failure Analysis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platinum Compounds; Prospective Studies | 2011 |
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Saphenous Vein; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome; United States | 2011 |
Paclitaxel-eluting stents compared with bare metal stents in diabetic patients with acute myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Stents; Treatment Outcome | 2011 |
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heparin; Hirudins; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recombinant Proteins; Risk Factors; Ticlopidine; Treatment Outcome; Tubulin Modulators | 2011 |
Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Stem Cells; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Death; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Proportional Hazards Models; Prospective Studies; Single-Blind Method; Sirolimus | 2011 |
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome; United States | 2011 |
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
Topics: Angioplasty, Balloon; Combined Modality Therapy; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recombinant Proteins; Stents; Survival Analysis; Time Factors; Treatment Outcome | 2011 |
Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Odds Ratio; Paclitaxel; Propensity Score; Proportional Hazards Models; Prosthesis Design; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Suction; Thrombectomy; Time Factors; Treatment Outcome | 2012 |
Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Period; Prosthesis Design; Sirolimus; Treatment Outcome | 2011 |
Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome.
Topics: Antineoplastic Agents, Phytogenic; Asian People; Disease-Free Survival; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Paclitaxel; Republic of Korea; Sirolimus; Survival Rate | 2011 |
Effectiveness of paclitaxel-eluting stents in complex clinical patients. -Insights from the TAXUS Japan Postmarket surveillance study.-.
Topics: Aged; Angioplasty; Antineoplastic Agents, Phytogenic; Death; Diabetes Complications; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prevalence; Product Surveillance, Postmarketing; Renal Dialysis; Retrospective Studies; Risk Factors | 2011 |
Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
Topics: Coronary Angiography; Coronary Restenosis; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Vascular Patency | 2011 |
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial).
Topics: Aged; Angioplasty, Balloon, Coronary; Antithrombins; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug Utilization; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Recombinant Proteins; Smoking; Stents | 2011 |
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome; United States | 2010 |
Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOM
Topics: Aged; Angiography; Angioplasty; Antineoplastic Agents; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Republic of Korea; Single-Blind Method; Sirolimus; Treatment Outcome | 2011 |
Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome | 2011 |
The PICCOLETO study and beyond.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Drug-Eluting Stents; Equipment Design; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Time Factors; Treatment Outcome | 2011 |
Comparison of the efficacy and safety of paclitaxel-eluting coroflex please stents and paclitaxel-eluting stents in patients with coronary artery disease: a randomized PIPA trial.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Republic of Korea; Single-Blind Method; Time Factors; Treatment Outcome | 2012 |
Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial.
Topics: Aged; Drug-Eluting Stents; Electrocardiography; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Sirolimus | 2012 |
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Stents; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Paclitaxel; Recurrence; Retrospective Studies; Sex Characteristics; Stents; Titanium; Treatment Outcome | 2012 |
A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of th
Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Feasibility Studies; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prosthesis Design; Risk Factors; Single-Blind Method; Stents; Time Factors; Treatment Outcome | 2012 |
Long-term follow-up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS-AMI trial.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Paclitaxel; Postoperative Complications; Treatment Outcome; Ultrasonography, Interventional | 2012 |
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Topics: Aged; Biomarkers; Blood Vessel Prosthesis Implantation; Creatine Kinase; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Practice Guidelines as Topic; Prognosis; Prospective Studies; Reference Standards; Sensitivity and Specificity; Sirolimus; Survival Analysis; Troponin; United States; United States Food and Drug Administration; World Health Organization | 2012 |
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cause of Death; Clopidogrel; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Stroke; Thrombosis; Ticlopidine; Treatment Outcome | 2012 |
Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy.
Topics: Aged; Biomarkers; Coronary Angiography; Cytokines; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Paclitaxel; Peroxidase; Placenta Growth Factor; Pregnancy Proteins; Tubulin Modulators | 2012 |
First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary p
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coated Materials, Biocompatible; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome | 2013 |
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2012 |
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial.
Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2012 |
Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.
Topics: Aged; Anticoagulants; Antithrombins; Coronary Angiography; Coronary Circulation; Drug-Eluting Stents; Electrocardiography; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Observer Variation; Paclitaxel; Peptide Fragments; Percutaneous Coronary Intervention; Predictive Value of Tests; Prognosis; Recombinant Proteins; Tubulin Modulators | 2012 |
Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Retrospective comparison of midterm clinical and angiographic outcomes after the implantation of paclitaxel- and sirolimus-eluting stents for de novo coronary complex lesions in nonrandomized Japanese patients.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Six-month angiographic and one-year clinical outcomes of polymer free paclitaxel-eluting stent in patients with ST-segment elevation myocardial infarction: a comparison with permanent polymer sirolimus-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Sirolimus; Treatment Outcome | 2012 |
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy.
Topics: Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Risk Factors; Treatment Outcome | 2013 |
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
Topics: Aged; Cohort Studies; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Treatment Outcome | 2013 |
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions.
Topics: Angioplasty, Balloon, Coronary; Asia; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Kaplan-Meier Estimate; Logistic Models; Myocardial Infarction; New Zealand; Paclitaxel; Propensity Score; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States | 2013 |
Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis.
Topics: Acute Disease; Aged; Blood Vessels; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Paclitaxel; Predictive Value of Tests; Sirolimus; Thrombosis; Treatment Outcome | 2012 |
High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; Vascular Calcification | 2013 |
Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease.
Topics: Aged; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Renal Insufficiency, Chronic; Republic of Korea; Sirolimus | 2012 |
Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial.
Topics: Aspirin; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Compliance; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Surveys and Questionnaires; Treatment Outcome | 2013 |
Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Single-Blind Method; Sirolimus; Treatment Outcome | 2013 |
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Disease-Free Survival; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Early outcome after paclitaxel-eluting stents in patients with acute and subacute myocardial infarction. A clinical study.
Topics: Age Distribution; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Stents; Survival Analysis; Treatment Outcome | 2004 |
Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery.
Topics: Administration, Topical; Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2005 |
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Single-Blind Method; Sirolimus; Stents; Survival Analysis | 2005 |
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Complications; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Regression Analysis; Sirolimus; Stents; Survival Analysis | 2005 |
Are paclitaxel-eluting stents safe and effective in patients with acute coronary syndromes?
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Restenosis; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Radiography; Risk Assessment; Stents; Survival Rate; Treatment Outcome | 2005 |
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Female; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome | 2006 |
Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Disease-Free Survival; District of Columbia; Female; Graft Occlusion, Vascular; Hospitalization; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Radiography; Saphenous Vein; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome | 2006 |
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Risk; Secondary Prevention; Single-Blind Method; Stents; Thrombosis | 2006 |
Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retreatment; Sirolimus; Treatment Outcome | 2006 |
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine | 2006 |
Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
Topics: Anti-Bacterial Agents; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2007 |
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
Topics: Angioplasty, Balloon, Coronary; Cause of Death; Clopidogrel; Cohort Studies; Coronary Restenosis; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Registries; Retrospective Studies; Sirolimus; Stents; Survival Rate; Ticlopidine; Treatment Outcome | 2007 |
Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Design; Research Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2007 |
Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Severity of Illness Index; Single-Blind Method; Stents; Treatment Outcome | 2007 |
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Survival Rate; Thrombosis; Ticlopidine; Tubulin Modulators | 2007 |
A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents.
Topics: Aged; Aged, 80 and over; Coronary Vessels; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Sirolimus; Stents | 2007 |
Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Sirolimus; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional | 2008 |
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome | 2008 |
"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Heparin; Hirudins; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Proportional Hazards Models; Recombinant Proteins; Risk Factors; Secondary Prevention; Sirolimus; Treatment Outcome | 2008 |
Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Radiography; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators | 2008 |
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Ultrasonography, Interventional | 2008 |
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group.
Topics: Aged; Death, Sudden, Cardiac; Drug Resistance; Estrogens; Gonadotropin-Releasing Hormone; Humans; Leukopenia; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prostatic Neoplasms; Survival Rate | 1993 |
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
243 other study(ies) available for paclitaxel and Cardiovascular Stroke
| Article | Year |
|---|---|
Pronounced late acquired focal coronary artery dilatation after paclitaxel-coated balloon angioplasty: observations from the randomized REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTIO
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Treatment Outcome | 2022 |
Acute and mid-term outcomes of drug-coated balloon following rotational atherectomy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome; Tubulin Modulators; Vascular Access Devices; Vascular Calcification | 2020 |
Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dissection; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2020 |
Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients Caused by Very Late Stent Thrombosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2017 |
Drug-coated balloon: Long-term outcome from a real world three-center experience.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Postoperative Complications; Registries; Retrospective Studies; Treatment Outcome | 2017 |
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; ST Elevation Myocardial Infarction; Treatment Outcome | 2017 |
Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Tomography, Optical Coherence; Tubulin Modulators | 2018 |
Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome.
Topics: Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome | 2019 |
Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients.
Topics: Aged; Angina, Stable; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Creatine Kinase, MB Form; Databases, Factual; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Troponin T | 2018 |
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
Topics: Aged; Coronary Artery Bypass; Drug-Eluting Stents; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Risk Factors; Shock, Cardiogenic; Treatment Outcome | 2019 |
Leaving Nothing Behind in Treatment of Acute Myocardial Infarction: Are We There Yet?
Topics: Angioplasty, Balloon; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Treatment Outcome | 2019 |
Incidence and predictors of target lesion failure in patients undergoing contemporary DES implantation-Individual patient data pooled analysis from 6 randomized controlled trials.
Topics: Antineoplastic Agents; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prospective Studies; Prosthesis Failure; Randomized Controlled Trials as Topic; Time Factors; Treatment Failure | 2019 |
Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2013 |
Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery.
Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Paclitaxel; Thrombocytosis; Ticlopidine; Withholding Treatment | 2013 |
Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Hospitals, High-Volume; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Topics: Aged; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2014 |
The end of ENDEAVOR IV: the stent comparison trial's final follow-up.
Topics: Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts.
Topics: Aged; Cardiovascular Agents; Coronary Artery Bypass; Drug-Eluting Stents; Everolimus; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Risk Factors; Saphenous Vein; Sirolimus; Switzerland; Time Factors; Treatment Outcome | 2014 |
[SICI-GISE position paper on drug-coated balloon use in the coronary district].
Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Equipment Design; Evidence-Based Medicine; Humans; Multicenter Studies as Topic; Myocardial Infarction; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Registries | 2013 |
Comparison of 2-year clinical outcomes between zotarolimus-, sirolimus-, and paclitaxel-eluting stents in real life clinical practice.
Topics: Aged; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2014 |
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prevalence; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Long-term safety and efficacy of the everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice.
Topics: Aged; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Sirolimus; Treatment Outcome | 2014 |
Drug-eluting balloon in the treatment of in-stent restenosis and diffuse coronary artery disease: real-world experience from our registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Outcome Assessment; Registries; Retrospective Studies; Stents | 2014 |
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Topics: Aged; Angina, Stable; Angina, Unstable; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tubulin Modulators; Ultrasonography, Interventional | 2014 |
"Very" very late stent thrombosis: acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation.
Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Drug-Eluting Stents; Female; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Sirolimus; Thrombosis; Time Factors | 2014 |
Insights into very late stent thrombosis from the wisdom of pathology.
Topics: Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis | 2014 |
Drug eluting balloon: a multipurpose tool for coronary revascularization with optimal long-term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries | 2014 |
Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Iowa; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Factors; Sex Factors; Sirolimus; Tertiary Care Centers; Time Factors; Treatment Outcome | 2014 |
Cost-effectiveness of drug-eluting vs. bare-metal stents in patients with coronary artery disease from the Korean National Health Insurance Database.
Topics: Aged; Angioplasty, Balloon, Coronary; Asian People; Coronary Artery Disease; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; National Health Programs; Paclitaxel; Republic of Korea; Retrospective Studies; Risk; Sirolimus; Stents; Treatment Outcome | 2014 |
Comparison of paclitaxel and everolimus-eluting stents in ST-segment elevation myocardial infarction and influence of thrombectomy on outcomes. ESTROFA-IM study.
Topics: Blood Vessel Prosthesis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Registries; Retrospective Studies; Thrombectomy; Treatment Outcome | 2014 |
Coronary aneurysm after paclitaxel-eluting balloon angioplasty.
Topics: Angioplasty, Balloon, Coronary; Coronary Aneurysm; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel | 2014 |
Paclitaxel-eluting stents in ST-segment elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2014 |
Microtubule stabilization with paclitaxel does not protect against infarction in isolated rat hearts.
Topics: Animals; Calcium Signaling; Colchicine; Cytoprotection; Dose-Response Relationship, Drug; Heart Rate; In Vitro Techniques; Male; Mechanotransduction, Cellular; Microtubules; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Paclitaxel; Rats, Sprague-Dawley; Stress, Mechanical; Tubulin Modulators; Ventricular Function, Left; Ventricular Pressure | 2015 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Clinical and angiographic outcomes of paclitaxel-eluting coronary stent implantation in hemodialysis patients: A prospective multicenter registry: The OUCH-TL study (outcome in hemodialysis of TAXUS Liberte).
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Renal Dialysis; Treatment Outcome; Tubulin Modulators; United States | 2015 |
Coronary artery rupture caused by stent infection: a rare complication.
Topics: Angina, Unstable; Anti-Bacterial Agents; Chest Pain; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Emergencies; Floxacillin; Fusidic Acid; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis-Related Infections; Rupture, Spontaneous; Staphylococcal Infections; Ultrasonography; Ventricular Dysfunction, Left | 2015 |
Comparisons of everolimus and Paclitaxel-eluting stents in patients with acute myocardial infarction.
Topics: Aged; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Prospective Studies; Registries; Republic of Korea; Time Factors; Treatment Outcome | 2015 |
Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients.
Topics: Aged; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Renal Dialysis; Treatment Outcome | 2015 |
Incidence, predictors and outcomes of immediate decrease in thrombolysis in myocardial infarction flow immediately after paclitaxel-coated balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Single-Blind Method; Thrombolytic Therapy; Treatment Outcome | 2015 |
Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Middle Aged; Myocardial Infarction; Paclitaxel; Receptor, ErbB-2; Risk Factors; Stroke Volume; Trastuzumab; Ventricular Function, Left; Young Adult | 2016 |
Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Registries; Republic of Korea; Time Factors; Treatment Outcome; Vascular Patency | 2016 |
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Sirolimus; Time; Treatment Outcome | 2016 |
Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).
Topics: Aged; Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Poland; Proportional Hazards Models; Registries; Retrospective Studies; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2015 |
The Leipzig Prospective Drug-Eluting Balloon-Registry - Outcome of 484 Consecutive Patients Treated for Coronary In-Stent Restenosis and De Novo Lesions Using Paclitaxel-Coated Balloons.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries | 2016 |
The Importance of Subgroup Analysis in Drug-Eluting Stent Trials.
Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Time Factors; Treatment Outcome | 2016 |
Paclitaxel-coated balloon angioplasty for de novo coronary lesions: a long-term follow-up study.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Treatment Outcome | 2016 |
Drug-Eluting Stents: Capable of Saving Lives in Dialysis Patients?
Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Drug-Eluting Stents; Humans; Metals; Myocardial Infarction; Paclitaxel; Renal Dialysis; Sirolimus; Stents; Treatment Outcome | 2016 |
Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; New South Wales; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Registries; Retreatment; Retrospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome | 2017 |
A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.
Topics: Aged; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Time Factors; Treatment Outcome | 2017 |
Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Cause of Death; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Treatment Outcome | 2017 |
Comparison of 5-year outcomes of paclitaxel-eluting and endeavor zotarolimus-eluting stents in New York.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Comparative Effectiveness Research; Coronary Artery Disease; Databases, Factual; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; New York; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2018 |
Drug-eluting stents in ST elevation myocardial infarction: In light of the PROSIT trial.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Treatment Outcome; Tubulin Modulators | 2008 |
Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Stents | 2008 |
One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
Topics: Adult; Aged; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Asia; Cardiac Catheterization; Central America; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Middle East; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Product Surveillance, Postmarketing; Prospective Studies; Registries; South America; Taxus; Treatment Outcome; Tubulin Modulators | 2008 |
Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Critical Pathways; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Stents; Survival Rate; Treatment Outcome | 2008 |
Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries; Sirolimus; Treatment Outcome | 2010 |
Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Prosthesis Failure; Recurrence; Retreatment; Sirolimus | 2010 |
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; California; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Critical Illness; Drug-Eluting Stents; Feasibility Studies; Female; Hospital Mortality; Humans; Italy; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Bypass; Coronary Artery Disease; Critical Illness; Drug-Eluting Stents; Hospital Mortality; Humans; Myocardial Infarction; Paclitaxel; Research Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome | 2010 |
Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.
Topics: Blood Platelets; Consensus; Coronary Thrombosis; Death; Drug-Eluting Stents; Humans; Incidence; Myocardial Infarction; Paclitaxel; Research Design; Thrombectomy | 2008 |
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis | 2009 |
Successful clopidogrel desensitization after drug-eluting stent implantation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Desensitization, Immunologic; Drug-Eluting Stents; Electrocardiography; Exanthema; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Pruritus; Ticlopidine | 2009 |
IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Aneurysm; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retreatment; Ultrasonography, Interventional | 2009 |
Left main coronary artery stenting: crossing the Rubicon.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Tubulin Modulators | 2009 |
Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Practice Guidelines as Topic; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2008 |
Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; New York; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Time Factors; Treatment Outcome | 2008 |
Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/un
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Factors; Sirolimus; Tomography, Optical Coherence | 2009 |
Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Ticlopidine | 2010 |
Long-term outcomes comparison of different types of DES in elderly patients from a real-world experience.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Registries; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Defining the optimal treatment for elderly patients: lessons from real-world data.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Italy; Male; Myocardial Infarction; Paclitaxel; Sirolimus | 2009 |
Drug-eluting coronary stents: many meta-analyses, little benefit.
Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Mid-term angiographic benefit of sirolimus-eluting stents compared with paclitaxel-eluting stents in patients with acute myocardial infarction.
Topics: Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Regression Analysis; Sirolimus; Treatment Outcome | 2009 |
Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2009 |
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States | 2009 |
Paclitaxel-induced myocardial infarction in a case of carcinoma ovary.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Female; Heart Arrest; Humans; Middle Aged; Myocardial Infarction; Ovarian Neoplasms; Paclitaxel | 2009 |
Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Reoperation; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Treatment Outcome | 2009 |
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Coronary Occlusion; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stents; Stroke | 2009 |
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromosomes, Human, Pair 9; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Comparison of long-term outcomes following sirolimus-eluting stent vs paclitaxel-eluting stent implantation in patients with long calcified coronary lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Calcinosis; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Republic of Korea; Retrospective Studies; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice.
Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; China; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Sirolimus | 2009 |
Primary percutaneous coronary intervention with drug-eluting stents: another chapter in the stent controversy.
Topics: Blood Vessel Prosthesis Implantation; Clinical Trials as Topic; Coronary Thrombosis; Coronary Vessels; Cost of Illness; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Risk Assessment; Sirolimus | 2008 |
Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Survival Analysis; Thrombosis; Time Factors; Treatment Outcome | 2008 |
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Occlusion; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Long-term paclitaxel-eluting stent outcomes in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Off-label use and the spectre of drug-eluting stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Off-Label Use; Paclitaxel; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Artery Disease; Diabetic Angiopathies; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Ontario; Paclitaxel; Proportional Hazards Models; Registries; Sirolimus; Tubulin Modulators | 2009 |
3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; England; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Renal Insufficiency; Retrospective Studies; Sirolimus | 2010 |
Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Calcinosis; Cardiovascular Agents; Coronary Restenosis; Disease-Free Survival; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Registries; Sirolimus; Treatment Failure; Treatment Outcome | 2010 |
Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2010 |
Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Bifurcation stenting: a commitment to always kiss.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Angiography; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Retrospective Studies; Sirolimus; Treatment Outcome | 2010 |
Drug-eluting stent versus bare-metal stent in acute ST-segment elevation myocardial infarction: a word of caution.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recurrence; Retreatment; Risk Assessment; Sirolimus; Survival Analysis; Treatment Outcome | 2010 |
The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography.
Topics: Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Tomography, Optical Coherence | 2010 |
Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Italy; Los Angeles; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2010 |
Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Glomerular Filtration Rate; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Male; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Sirolimus; Treatment Outcome; United States | 2010 |
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Diabetes Complications; Drug-Eluting Stents; Female; Heart Diseases; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Recurrence; Registries; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Sirolimus versus paclitaxel coronary stents in clinical practice.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Switzerland; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Procedure-related myonecrosis after bare and drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cardiovascular Agents; Creatine Kinase, MB Form; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Male; Metals; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Prosthesis Design; Retrospective Studies; Singapore; Sirolimus; Stents; Time Factors; Treatment Outcome; Up-Regulation | 2010 |
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Denmark; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry).
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Hospital Mortality; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Clinical and angiographic outcomes of drug-eluting stents in patients with large vessel and single coronary artery lesion.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Hospital Mortality; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Taxol, a microtubule stabilizer, prevents ischemic ventricular arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Electron Transport Chain Complex Proteins; Myocardial Infarction; Paclitaxel; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tubulin Modulators | 2011 |
Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome | 2010 |
An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Another small step for small vessels.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cohort Studies; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2010 |
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; ROC Curve; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Complete resolution of very late stent thrombosis with systemic thrombolysis.
Topics: Adult; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Thrombolytic Therapy; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Pharmacoinvasive strategy for ST-segment elevation myocardial infarction: wading through the treatment options.
Topics: Angioplasty; Anticoagulants; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine; Ultrasonography | 2010 |
Taxol inhibits stretch-induced electrophysiological alterations in isolated rat hearts with acute myocardial infarction.
Topics: Animals; Heart; Myocardial Infarction; Paclitaxel; Rats; Rats, Wistar | 2010 |
Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry.
Topics: Africa, Northern; Aged; Angioplasty, Balloon, Coronary; Asia; Cardiovascular Agents; Diabetes Mellitus; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Practice Patterns, Physicians'; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Regression Analysis; Risk Assessment; Risk Factors; South America; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Crush stenting with drug-eluting stents: relevance of coronary bifurcation lesion location on angiographic and clinical outcomes.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Clinical outcome and angiographic results with novel polysulfone polymer coating paclitaxel eluting stent in real-world clinical practice: a clinical centre registry.
Topics: Aged; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Registries; Sulfones; Time Factors; Treatment Outcome | 2010 |
Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea.
Topics: Aged; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Renal Insufficiency; Republic of Korea; Sirolimus; Stents; Treatment Outcome | 2012 |
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEA
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2010 |
More openness and a little less strut: two good ideas for stents and the people who implant them.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Evidence-Based Medicine; Humans; Myocardial Infarction; Necrosis; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2010 |
The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Humans; Hypersensitivity; Myocardial Infarction; Paclitaxel; Prosthesis Design; Sirolimus; Syndrome; Thrombosis; Treatment Outcome | 2010 |
Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Cardiovascular Agents; Chi-Square Distribution; Cineangiography; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Japan; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2011 |
High glycemic stenting menu.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Humans; Hypoglycemic Agents; Insulin; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2010 |
[Inhospital and 12-months results of percutaneous coronary interventions with implantation of Paclitaxel eluting stents in patients with long de novo coronary artery lesions].
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Plaque, Atherosclerotic; Treatment Outcome; Tubulin Modulators | 2010 |
Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; England; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome | 2011 |
Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Confidence Intervals; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Poisson Distribution; Registries; Risk Factors; Sex Factors; Time Factors; Treatment Outcome | 2010 |
Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Metals; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Myocardial Infarction; North Carolina; Paclitaxel; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Recurrence; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome | 2011 |
If I've heard it once, I've heard it (not yet) a hundred times.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Combination of direct and adjusted indirect comparisons of sirolimus- versus paclitaxel-eluting stents for ST-segment elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Tubulin Modulators | 2011 |
Two-Year outcomes after utilization of the TAXUS paclitaxel-eluting stent in bifurcations and multivessel stenting in the ARRIVE registries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prospective Studies; Registries; Treatment Outcome | 2011 |
Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome | 2011 |
Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Saphenous Vein; Sirolimus; Stents; Time Factors; Treatment Outcome | 2012 |
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme.
Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Thrombosis; Treatment Outcome | 2011 |
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stents.
Topics: Chi-Square Distribution; Clinical Trials as Topic; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Prosthesis Design; Risk Assessment; Risk Factors; Treatment Outcome; Tubulin Modulators | 2011 |
Interventional cardiology: Antithrombotic drug and stent choices in primary PCI.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Fibrinolytic Agents; Hirudins; Humans; Myocardial Infarction; Paclitaxel; Peptide Fragments; Prosthesis Design; Randomized Controlled Trials as Topic; Recombinant Proteins; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Long-term benefit using DES in STEMI patients.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Sirolimus; Stents | 2011 |
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology ho
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Registries; Regression Analysis; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2011 |
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; France; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Italy; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarction.
Topics: Aged; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Registries; Retrospective Studies; Sirolimus; Treatment Outcome | 2013 |
Bivalirudin for patients with ST-elevation myocardial infarction.
Topics: Angioplasty, Balloon; Female; Heparin; Hirudins; Humans; Male; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex | 2011 |
Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prognosis; Shock, Cardiogenic; Sirolimus; Stents; Tubulin Modulators | 2012 |
Outcomes in contemporary coronary interventions with drug-eluting stents for acute myocardial infarction: the gender role.
Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Sex Characteristics; Stents; Titanium | 2012 |
Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Postoperative Complications; Sirolimus; Survival Analysis; Treatment Outcome | 2012 |
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Guideline Adherence; Hospital Mortality; Humans; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Practice Guidelines as Topic; Product Labeling; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2012 |
Influence of diabetes mellitus on long-term (five-year) outcomes of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Retreatment; Sirolimus; Stroke | 2012 |
Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
Topics: Aged; Aged, 80 and over; Atherectomy, Coronary; Cardiovascular Agents; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Incidence; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome; Vascular Calcification | 2013 |
Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Disease-Free Survival; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2013 |
A range of options: an alternative to "my way or the highway" interpretation of guidelines.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Female; Humans; Male; Metals; Myocardial Infarction; Paclitaxel; Stents; Thrombectomy | 2012 |
The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga.
Topics: Blood Vessel Prosthesis Implantation; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Postoperative Complications; Practice Guidelines as Topic; Sirolimus | 2012 |
Very late thrombosis of a paclitaxel-eluting stent after 72 months in a patient on dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Echocardiography; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2012 |
Post-discharge clinical and angiographic outcomes of patients presenting within 48h of STEMI treated with paclitaxel- or sirolimus-eluting stents.
Topics: Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome | 2012 |
Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: results of a real-life multicenter registry.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Italy; Kaplan-Meier Estimate; Logistic Models; Male; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Propensity Score; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Time Factors; Treatment Outcome | 2013 |
Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents.
Topics: Cardiotonic Agents; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Racial Groups; Randomized Controlled Trials as Topic; Thrombosis | 2013 |
Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry.
Topics: Aged; Aged, 80 and over; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Equipment Failure; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Risk Factors; Treatment Outcome | 2012 |
Dual antiplatelet therapy after stenting. More than 12 months of treatment might not be necessary.
Topics: Aspirin; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Patient Education as Topic; Time Factors; United States | 2012 |
Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up.
Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Pilot Projects; Retrospective Studies; Saphenous Vein; Sirolimus; Treatment Outcome | 2012 |
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Angina, Stable; Cardiovascular Agents; Coronary Stenosis; Coronary Thrombosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Poland; Polymers; Propensity Score; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Safety and efficacy of overlapping homogenous drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction Registry.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Coronary Angiography; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Proportional Hazards Models; Registries; Republic of Korea; Sirolimus; Survival Analysis | 2012 |
Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
Topics: Aged; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Renal Insufficiency; Retrospective Studies; Sirolimus; Stents | 2013 |
Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent.
Topics: Alkaline Phosphatase; Blood Vessel Prosthesis Implantation; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Tubulin Modulators | 2013 |
Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Prosthesis Design; Registries; Republic of Korea; Retrospective Studies; Risk Factors; Stainless Steel; Time Factors; Treatment Outcome | 2013 |
Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
Topics: Aged; Aged, 80 and over; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Sirolimus; Thrombosis; Treatment Outcome | 2013 |
The use of putative placebo in active control trials: two applications in a regulatory setting.
Topics: Angina, Unstable; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase III as Topic; Confidence Intervals; Data Interpretation, Statistical; Docetaxel; Doxorubicin; Enoxaparin; Female; Fibrinolytic Agents; Humans; Myocardial Infarction; Odds Ratio; Paclitaxel; Placebos; Randomized Controlled Trials as Topic; Taxoids; Therapeutic Equivalency | 2003 |
Acute myocardial infarction and cardiac arrest in a patient receiving paclitaxel.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Coronary Angiography; Electrocardiography; Heart Arrest; Heart Conduction System; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Myocardial Infarction; Paclitaxel | 2003 |
Cardiotoxicities of paclitaxel in African Americans.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Black People; Electrocardiography; Female; Heart; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Risk Factors | 2003 |
Late thrombotic occlusion of paclitaxel eluting stent more than one year after stent implantation.
Topics: Adult; Cardiovascular Agents; Coronary Angiography; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Paclitaxel; Protective Agents; Stents | 2004 |
Delayed healing of a coronary artery plaque ulceration associated with acute myocardial infarction related to a paclitaxel-eluting stent.
Topics: Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Artery Disease; Diagnosis, Differential; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Ultrasonography, Interventional | 2005 |
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Drug Delivery Systems; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk; Sirolimus; Stents; Thrombosis | 2005 |
Drug-eluting stents in acute myocardial infarction: is science catching up with practice?
Topics: Angioplasty, Balloon, Coronary; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents | 2005 |
One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Restenosis; Drug Delivery Systems; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Treatment Outcome | 2005 |
Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice.
Topics: Aged; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Practice Patterns, Physicians'; Retrospective Studies; Sirolimus; Stents; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Acute myocardial infarction caused by late stent thrombosis after deployment of a paclitaxel-eluting stent.
Topics: Acute Disease; Coronary Angiography; Drug Delivery Systems; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Thromboembolism; Time Factors | 2005 |
Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).
Topics: Aged; Angina, Unstable; Diabetes Complications; Female; Humans; Immunosuppressive Agents; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2005 |
[Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation].
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Cardiomyopathy, Dilated; Heart Transplantation; Heart-Assist Devices; Humans; Leg; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Thrombosis; Vascular Surgical Procedures | 2005 |
Possible anaphylactic reaction to taxus stent: a case report.
Topics: Anaphylaxis; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents | 2005 |
Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Severity of Illness Index; Sirolimus; Stents; Survival Rate; Time Factors; Treatment Outcome | 2005 |
Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.
Topics: Adult; Aged; Coronary Restenosis; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Stents | 2006 |
[Insulin-dependent. Rapamycin-resistant?].
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Cost-Benefit Analysis; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Delivery Systems; Female; Humans; Hypertension; Immunosuppressive Agents; Incidence; Male; Meta-Analysis as Topic; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus; Stents; Treatment Outcome | 2006 |
Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Canada; Coronary Thrombosis; Drug Delivery Systems; Electrocardiography; Female; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Stents; Treatment Outcome | 2006 |
Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Life Tables; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pleural Diseases; Pneumonectomy; Pneumonia; Pneumonia, Aspiration; Postoperative Complications; Pulmonary Embolism; Radiotherapy Dosage; Radiotherapy, Conformal; Remission Induction; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Tract Fistula; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
Topics: Adult; Aged; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden, Cardiac; Female; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Wound Healing | 2006 |
Very late [corrected] thrombosis of a sirolimus-eluting stent.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Paclitaxel; Reoperation; Sirolimus; Stents | 2006 |
Drug-eluting stents in acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Stents | 2006 |
Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Korea; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Revascularization; Outcome Assessment, Health Care; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Ventricular Dysfunction, Left | 2006 |
Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction.
Topics: Adult; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Retreatment; Risk Assessment; Thrombectomy; Time Factors | 2006 |
Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Topics: Aged; Coronary Stenosis; Data Collection; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2006 |
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
Topics: Aged; Anti-Inflammatory Agents; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2006 |
Left main coronary artery thrombectomy and stenting using a paclitaxel-eluting stent in the setting of acute myocardial infarction.
Topics: Adult; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Vessels; Humans; Male; Myocardial Infarction; Paclitaxel; Stents; Thrombolytic Therapy; Treatment Outcome | 2006 |
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Drug Delivery Systems; Equipment Design; Humans; Incidence; Metals; Myocardial Infarction; Paclitaxel; Registries; Retreatment; Risk Assessment; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2006 |
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2007 |
Drug-eluting stents in primary PCI.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Research Design; Sirolimus; Stents | 2006 |
Drug-eluting stents in primary PCI.
Topics: Angioplasty, Balloon, Coronary; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary Restenosis; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis | 2006 |
One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Reoperation; Research Design; Spain; Stents; Time Factors; Treatment Outcome | 2007 |
Very late stent thrombosis after implantation of drug eluting stent.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Time Factors | 2006 |
In-stent thrombosis after discontinuation of antiplatelet therapy 2 years after DES implantation: a case report.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Stents | 2007 |
Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Survival Rate; United States | 2007 |
Bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Anticoagulants; Coronary Artery Disease; Costs and Cost Analysis; Drug Delivery Systems; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Length of Stay; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Sirolimus; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2007 |
Bivalirudin and DES: a PCI strategy that pays.
Topics: Anticoagulants; Coronary Artery Disease; Costs and Cost Analysis; Drug Delivery Systems; Heparin; Hirudins; Humans; Immunosuppressive Agents; Length of Stay; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Sirolimus; Stents | 2007 |
Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Databases as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2007 |
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Registries; Risk; Sirolimus; Stents; Sweden | 2007 |
Unanswered questions--drug-eluting stents and the risk of late thrombosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Device Approval; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk; Sirolimus; Stents; United States; United States Food and Drug Administration | 2007 |
Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Coronary Restenosis; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prognosis; Stents | 2007 |
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Topics: Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Cohort Studies; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Survival Analysis; Time Factors | 2007 |
Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Disease; Depression; Fatigue; Female; Humans; Male; Middle Aged; Motivation; Myocardial Infarction; Paclitaxel; Prognosis; Proportional Hazards Models; Risk Factors; Stents; Survival Rate | 2007 |
Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes.
Topics: Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Coronary Vessel Anomalies; Drug Delivery Systems; Female; Heart Defects, Congenital; Humans; Male; Myocardial Infarction; Paclitaxel; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Survival Analysis; Time Factors; Treatment Outcome; Vascular Patency | 2007 |
Late coronary thrombosis in paclitaxel-eluting stents. Case reports.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Thrombosis; Time Factors | 2007 |
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug Implants; Drug Utilization; Endothelium, Vascular; Equipment Design; Equipment Failure; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Tunica Intima; Wound Healing | 2007 |
Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.
Topics: Blood Vessel Prosthesis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prosthesis Failure; Sirolimus; Treatment Outcome; Ultrasonography | 2007 |
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Surface Properties; Ticlopidine; Treatment Outcome | 2007 |
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2007 |
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Feasibility Studies; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Secondary Prevention; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Autopsy; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Endothelial Cells; Fatal Outcome; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Thrombosis; Ticlopidine; Treatment Outcome | 2008 |
Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.
Topics: Aged; Coronary Restenosis; Coronary Thrombosis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2007 |
Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Outcome Assessment, Health Care; Paclitaxel; Prospective Studies; Registries; Sirolimus; Stents; United States | 2007 |
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Diabetic Angiopathies; Follow-Up Studies; Humans; Immunosuppressive Agents; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Risk Factors; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2007 |
A serial ultrasound assessment of neoaneurysm following paclitaxel-eluting stent implantation.
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Aneurysm; Female; Humans; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Ultrasonography, Interventional | 2007 |
Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Consumer Product Safety; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Treatment Outcome | 2007 |
A case of very late stent thrombosis at high altitude.
Topics: Adult; Altitude; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Contraceptives, Oral; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dehydration; Drug-Eluting Stents; Exercise; Female; Genetic Predisposition to Disease; Humans; Hypoxia; Myocardial Infarction; Paclitaxel; Risk Factors; Time Factors; Treatment Outcome | 2007 |
Safety of drug-eluting stents: demystifying network meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Meta-Analysis as Topic; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents | 2007 |
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2008 |
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Multivariate Analysis; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Retreatment; Saphenous Vein; Sirolimus; Stents; Thrombosis | 2008 |
One year clinical and six month angiographic results of drug eluting stents for ST elevation acute myocardial infarction: 'real world' comparison between sirolimus- and paclitaxel-eluting stents.
Topics: Aged; Coronary Angiography; Drug-Eluting Stents; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome | 2009 |
Effectiveness of drug-eluting stents in real-world patients.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis | 2008 |
Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry.
Topics: Acute Disease; Aged; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Korea; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Registries; Risk Factors; Sirolimus; Treatment Outcome | 2008 |
Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Paclitaxel; Patient Selection; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2008 |
Stenting unprotected left main: the outcome is not always favorable.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2008 |
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Registries; Sirolimus; Stroke Volume | 2008 |
Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
Topics: Aged; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Statistics, Nonparametric | 2008 |
Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN).
Topics: Ablation Techniques; Angina Pectoris; Antineoplastic Agents, Phytogenic; Cardiology; Clinical Trials as Topic; Coronary Artery Disease; Drug-Eluting Stents; Equipment Design; Germany; Heart Failure; Humans; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Registries; Societies, Medical | 2008 |
Fatal myocardial infarction potentially induced by paclitaxel.
Topics: Aged; Breast Neoplasms; Carcinoma; Fatal Outcome; Female; Humans; Myocardial Infarction; Neoplasm Staging; Paclitaxel | 1996 |
Acute myocardial infarction following paclitaxel administration for ovarian carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Female; Humans; Middle Aged; Myocardial Infarction; Ovarian Neoplasms; Paclitaxel | 1997 |
Late acute thrombosis after paclitaxel eluting stent implantation.
Topics: Acute Disease; Angiogenesis Inhibitors; Aspirin; Coronary Disease; Coronary Thrombosis; Drug Implants; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Ticlopidine; Time Factors | 2001 |
Cardiac disturbances during the administration of taxol.
Topics: Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Female; Humans; Male; Microtubules; Middle Aged; Myocardial Infarction; Neoplasms; Paclitaxel; Tachycardia | 1991 |